HRP20211380T1 - Derivati pirimidina kao modulatori receptora pge2 - Google Patents
Derivati pirimidina kao modulatori receptora pge2 Download PDFInfo
- Publication number
- HRP20211380T1 HRP20211380T1 HRP20211380TT HRP20211380T HRP20211380T1 HR P20211380 T1 HRP20211380 T1 HR P20211380T1 HR P20211380T T HRP20211380T T HR P20211380TT HR P20211380 T HRP20211380 T HR P20211380T HR P20211380 T1 HRP20211380 T1 HR P20211380T1
- Authority
- HR
- Croatia
- Prior art keywords
- pyrimidin
- ethylamino
- benzo
- ethoxy
- image
- Prior art date
Links
- 102000008866 Prostaglandin E receptors Human genes 0.000 title 1
- 108010088540 Prostaglandin E receptors Proteins 0.000 title 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
- -1 cycloprop-1,1-diyl group Chemical group 0.000 claims 174
- 125000000217 alkyl group Chemical group 0.000 claims 37
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 36
- 229910052739 hydrogen Inorganic materials 0.000 claims 35
- 239000001257 hydrogen Substances 0.000 claims 35
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 28
- 125000000753 cycloalkyl group Chemical group 0.000 claims 28
- 150000001875 compounds Chemical class 0.000 claims 19
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 19
- 125000004430 oxygen atom Chemical group O* 0.000 claims 19
- 150000003839 salts Chemical class 0.000 claims 15
- 125000001424 substituent group Chemical group 0.000 claims 14
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 13
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 13
- 125000003545 alkoxy group Chemical group 0.000 claims 10
- 206010028980 Neoplasm Diseases 0.000 claims 9
- 229910052736 halogen Inorganic materials 0.000 claims 9
- 150000002367 halogens Chemical class 0.000 claims 9
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 8
- 201000011510 cancer Diseases 0.000 claims 7
- 125000002947 alkylene group Chemical group 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 6
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 125000004043 oxo group Chemical group O=* 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 4
- 229910052717 sulfur Chemical group 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 3
- 125000002993 cycloalkylene group Chemical group 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Chemical group 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- IAUADXBOWPHFJB-UHFFFAOYSA-N 3-[2-ethoxy-4-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenyl]-2H-1,2,4-oxadiazole-5-thione Chemical compound CCOC1=C(C=CC(=C1)C1=CC(NCCC2=C(C)C3=CC=CC=C3C=C2)=NC=N1)C1=NOC(S)=N1 IAUADXBOWPHFJB-UHFFFAOYSA-N 0.000 claims 2
- DRZPPOHRKRYJNO-UHFFFAOYSA-N 3-[2-ethoxy-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]-4H-1,2,4-oxadiazol-5-one Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)C1=NOC(N1)=O DRZPPOHRKRYJNO-UHFFFAOYSA-N 0.000 claims 2
- SSETUHKFCWROIN-UHFFFAOYSA-N 5-[2-ethoxy-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]-1,2-oxazol-3-one Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)C1=CC(=NO1)O SSETUHKFCWROIN-UHFFFAOYSA-N 0.000 claims 2
- MLWNSVCDPCYGJT-UHFFFAOYSA-N 5-[4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methoxyphenyl]-1,2-oxazol-3-one Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)C1=CC(=NO1)O)OC MLWNSVCDPCYGJT-UHFFFAOYSA-N 0.000 claims 2
- 208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 claims 2
- QTKPSJHMOVBCQP-UHFFFAOYSA-N C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1C)C1=NOC(N1)=O Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1C)C1=NOC(N1)=O QTKPSJHMOVBCQP-UHFFFAOYSA-N 0.000 claims 2
- ZLWFDOKXWKWTQU-UHFFFAOYSA-N C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1OC)C1=NOC(N1)=O Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1OC)C1=NOC(N1)=O ZLWFDOKXWKWTQU-UHFFFAOYSA-N 0.000 claims 2
- HBDVIYUBGYEGIL-UHFFFAOYSA-N C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC=C2C=CNC2=C1)C1=NOC(N1)=O Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC=C2C=CNC2=C1)C1=NOC(N1)=O HBDVIYUBGYEGIL-UHFFFAOYSA-N 0.000 claims 2
- SJBCVOFICHXQFN-UHFFFAOYSA-N C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C2C=CC=NC2=CC=1F)C1=NOC(N1)=O Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C2C=CC=NC2=CC=1F)C1=NOC(N1)=O SJBCVOFICHXQFN-UHFFFAOYSA-N 0.000 claims 2
- NLZWDKBWWDEORO-UHFFFAOYSA-N C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C2C=CNC2=CC=1)C1=NOC(N1)=O Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C2C=CNC2=CC=1)C1=NOC(N1)=O NLZWDKBWWDEORO-UHFFFAOYSA-N 0.000 claims 2
- AHVBCTXWALXLQJ-UHFFFAOYSA-N C(C)OC=1N=C(SC=1C1=NOC(N1)=O)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C Chemical compound C(C)OC=1N=C(SC=1C1=NOC(N1)=O)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C AHVBCTXWALXLQJ-UHFFFAOYSA-N 0.000 claims 2
- MGRKHQCOOKRBFT-UHFFFAOYSA-N CCOc1cc(sc1-c1nc(=O)o[nH]1)-c1cc(NCCc2ccc3OCOc3c2)ncn1 Chemical compound CCOc1cc(sc1-c1nc(=O)o[nH]1)-c1cc(NCCc2ccc3OCOc3c2)ncn1 MGRKHQCOOKRBFT-UHFFFAOYSA-N 0.000 claims 2
- NRRZENWPIWMAKM-UHFFFAOYSA-N CCc1nc(sc1-c1nc(=O)o[nH]1)-c1cc(NCCc2ccc3ccccc3c2C)ncn1 Chemical compound CCc1nc(sc1-c1nc(=O)o[nH]1)-c1cc(NCCc2ccc3ccccc3c2C)ncn1 NRRZENWPIWMAKM-UHFFFAOYSA-N 0.000 claims 2
- 201000009273 Endometriosis Diseases 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 230000003143 atherosclerotic effect Effects 0.000 claims 2
- 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 claims 2
- 125000004533 benzofuran-5-yl group Chemical group O1C=CC2=C1C=CC(=C2)* 0.000 claims 2
- 125000004540 benzothiazol-5-yl group Chemical group S1C=NC2=C1C=CC(=C2)* 0.000 claims 2
- 229940127089 cytotoxic agent Drugs 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000035558 fertility Effects 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 210000000987 immune system Anatomy 0.000 claims 2
- 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 claims 2
- 230000000302 ischemic effect Effects 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- 238000001959 radiotherapy Methods 0.000 claims 2
- 230000007420 reactivation Effects 0.000 claims 2
- 239000011593 sulfur Chemical group 0.000 claims 2
- 125000004434 sulfur atom Chemical group 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 238000002626 targeted therapy Methods 0.000 claims 2
- 125000004607 1,2,3,4-tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 claims 1
- RKKFNFCRPPQVHO-UHFFFAOYSA-N 2-(difluoromethoxy)-4-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound FC(OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C)F RKKFNFCRPPQVHO-UHFFFAOYSA-N 0.000 claims 1
- KIONIRQNHYPKSU-UHFFFAOYSA-N 2-[2-(difluoromethoxy)-4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound FC(OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)C)CC(=O)O)F KIONIRQNHYPKSU-UHFFFAOYSA-N 0.000 claims 1
- RQWGAAGBRRIDGD-UHFFFAOYSA-N 2-[2-(difluoromethoxy)-4-[6-[2-(5-fluoro-7-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound FC(OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1OC)F)CC(=O)O)F RQWGAAGBRRIDGD-UHFFFAOYSA-N 0.000 claims 1
- ZDFQXNXIEVAZSA-UHFFFAOYSA-N 2-[2-(difluoromethoxy)-4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound FC(OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OCC)CC(=O)O)F ZDFQXNXIEVAZSA-UHFFFAOYSA-N 0.000 claims 1
- WTCXDTXTQBBALP-UHFFFAOYSA-N 2-[2-(difluoromethoxy)-4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound FC(OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1OC)C)CC(=O)O)F WTCXDTXTQBBALP-UHFFFAOYSA-N 0.000 claims 1
- JHNSYBZXMAMJST-UHFFFAOYSA-N 2-[2-chloro-6-ethyl-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound ClC1=C(C(=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)CC)CC(=O)O JHNSYBZXMAMJST-UHFFFAOYSA-N 0.000 claims 1
- XNFXHUOQAYYYFT-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(1-fluoro-3-methoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)F)CC(=O)O XNFXHUOQAYYYFT-UHFFFAOYSA-N 0.000 claims 1
- OQFWFTXONUXMOZ-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(3-ethoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OCC)C)CC(=O)O OQFWFTXONUXMOZ-UHFFFAOYSA-N 0.000 claims 1
- PONUIMWKJAGNFL-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(3-ethoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1OCC PONUIMWKJAGNFL-UHFFFAOYSA-N 0.000 claims 1
- JRRDXBVIIGOMRM-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(3-ethynylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1C#C JRRDXBVIIGOMRM-UHFFFAOYSA-N 0.000 claims 1
- QRYFVGLKTZCVQR-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)C)CC(=O)O QRYFVGLKTZCVQR-UHFFFAOYSA-N 0.000 claims 1
- UWYGTGUPSLOZHY-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(3-methoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1OC UWYGTGUPSLOZHY-UHFFFAOYSA-N 0.000 claims 1
- ZJMMPAHNHBAYNZ-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(3-propan-2-yloxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1OC(C)C ZJMMPAHNHBAYNZ-UHFFFAOYSA-N 0.000 claims 1
- KMOJTRYMLJKSSI-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(SC=C2)C=C1)F)CC(=O)O KMOJTRYMLJKSSI-UHFFFAOYSA-N 0.000 claims 1
- FVVHAHYELUPKFH-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(5-methoxy-1-benzofuran-6-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(C=CO2)C=C1OC FVVHAHYELUPKFH-UHFFFAOYSA-N 0.000 claims 1
- VNYKPKZCQQXCCN-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-ethoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1OCC VNYKPKZCQQXCCN-UHFFFAOYSA-N 0.000 claims 1
- QMRJLRSVGOEGRG-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-6-fluorophenyl]acetic acid Chemical compound C(C)OC1=C(C(=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OCC)F)CC(=O)O QMRJLRSVGOEGRG-UHFFFAOYSA-N 0.000 claims 1
- YYGIGGSIQPRTKL-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OCC YYGIGGSIQPRTKL-UHFFFAOYSA-N 0.000 claims 1
- ZFLQHLCCYQSUCT-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OCC)CC(=O)O ZFLQHLCCYQSUCT-UHFFFAOYSA-N 0.000 claims 1
- LVIPPUGQNCDWQZ-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-fluoro-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1)F LVIPPUGQNCDWQZ-UHFFFAOYSA-N 0.000 claims 1
- YKZVZANWVARNFS-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-methoxy-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1)OC YKZVZANWVARNFS-UHFFFAOYSA-N 0.000 claims 1
- HTDYKLXJWRAUQH-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-methoxy-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]phenoxy]propanoic acid Chemical compound C(C)OC1=C(OC(C(=O)O)C)C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1)OC HTDYKLXJWRAUQH-UHFFFAOYSA-N 0.000 claims 1
- ZQKFQOGMUHUXAK-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-methoxy-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1)OC)CC(=O)O ZQKFQOGMUHUXAK-UHFFFAOYSA-N 0.000 claims 1
- WEYBQOJYNCNXJT-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1OC WEYBQOJYNCNXJT-UHFFFAOYSA-N 0.000 claims 1
- ORRFZNBFGHTUCT-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1OC)CC(=O)O ORRFZNBFGHTUCT-UHFFFAOYSA-N 0.000 claims 1
- FNXYQOMVCYQJHD-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OC FNXYQOMVCYQJHD-UHFFFAOYSA-N 0.000 claims 1
- CKHMZTVLUNYGEK-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-methoxy-4-methyl-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1C)OC CKHMZTVLUNYGEK-UHFFFAOYSA-N 0.000 claims 1
- LMNCNHSINKGPRZ-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-methoxy-4-methyl-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1C)OC)CC(=O)O LMNCNHSINKGPRZ-UHFFFAOYSA-N 0.000 claims 1
- QBEWNACGCZOAAT-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]-2-oxoacetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)C(C(=O)O)=O QBEWNACGCZOAAT-UHFFFAOYSA-N 0.000 claims 1
- CTZJOCZOIMHDJU-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)CC(=O)O CTZJOCZOIMHDJU-UHFFFAOYSA-N 0.000 claims 1
- LURFEAJTFZWXSW-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(7-fluoro-6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1OC)F)CC(=O)O LURFEAJTFZWXSW-UHFFFAOYSA-N 0.000 claims 1
- QJCFDYKDWAWNIV-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1OC)C)CC(=O)O QJCFDYKDWAWNIV-UHFFFAOYSA-N 0.000 claims 1
- LFSZNKPJDGWMJY-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(7-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1C LFSZNKPJDGWMJY-UHFFFAOYSA-N 0.000 claims 1
- HNIMEFSRGAFFIQ-UHFFFAOYSA-N 2-[2-ethoxy-6-fluoro-4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C(=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)C)F)CC(=O)O HNIMEFSRGAFFIQ-UHFFFAOYSA-N 0.000 claims 1
- XVTBFBOMKTZQGG-UHFFFAOYSA-N 2-[2-ethoxy-6-fluoro-4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C(=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(SC=C2)C=C1)F)F)CC(=O)O XVTBFBOMKTZQGG-UHFFFAOYSA-N 0.000 claims 1
- PYOHDHMORFMFPU-UHFFFAOYSA-N 2-[2-ethoxy-6-fluoro-4-[6-[2-(4-methyl-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C(=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(SC=C2)C=C1)C)F)CC(=O)O PYOHDHMORFMFPU-UHFFFAOYSA-N 0.000 claims 1
- IMCMITYHYCMPFG-UHFFFAOYSA-N 2-[2-ethoxy-6-fluoro-4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C(=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1OC)F)CC(=O)O IMCMITYHYCMPFG-UHFFFAOYSA-N 0.000 claims 1
- KXBLIBGCVULMOP-UHFFFAOYSA-N 2-[2-ethoxy-6-fluoro-4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)OC1=C(C(=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1OC)C)F)CC(=O)O KXBLIBGCVULMOP-UHFFFAOYSA-N 0.000 claims 1
- LPHVFYUNSCQVRE-UHFFFAOYSA-N 2-[2-ethyl-4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)C1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)C)CC(=O)O LPHVFYUNSCQVRE-UHFFFAOYSA-N 0.000 claims 1
- FVRNKSRNLIBYBK-UHFFFAOYSA-N 2-[2-ethyl-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-6-methylphenyl]acetic acid Chemical compound C(C)C1=C(C(=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)C)CC(=O)O FVRNKSRNLIBYBK-UHFFFAOYSA-N 0.000 claims 1
- MPYXNTWMRWNQHJ-UHFFFAOYSA-N 2-[2-ethyl-4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound C(C)C1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1OC)C)CC(=O)O MPYXNTWMRWNQHJ-UHFFFAOYSA-N 0.000 claims 1
- ZHKMHWWTRNNRRJ-UHFFFAOYSA-N 2-[2-methoxy-4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound COC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)C)CC(=O)O ZHKMHWWTRNNRRJ-UHFFFAOYSA-N 0.000 claims 1
- NZBWZSWTIRJIDK-UHFFFAOYSA-N 2-[2-methoxy-4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound COC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1OC)CC(=O)O NZBWZSWTIRJIDK-UHFFFAOYSA-N 0.000 claims 1
- FFJCSGNDNDAGLX-UHFFFAOYSA-N 2-[2-methoxy-4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound COC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OC)CC(=O)O FFJCSGNDNDAGLX-UHFFFAOYSA-N 0.000 claims 1
- HEMFIHQNXWGKKA-UHFFFAOYSA-N 2-[2-methoxy-4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]phenyl]acetic acid Chemical compound COC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1OC)C)CC(=O)O HEMFIHQNXWGKKA-UHFFFAOYSA-N 0.000 claims 1
- KYBDABRDPUZHLC-UHFFFAOYSA-N 2-[3-(difluoromethoxy)-5-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]acetic acid Chemical compound FC(OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)CC(=O)O)F KYBDABRDPUZHLC-UHFFFAOYSA-N 0.000 claims 1
- MSIAENYHKNIWCG-UHFFFAOYSA-N 2-[3-ethoxy-5-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]acetic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C)CC(=O)O MSIAENYHKNIWCG-UHFFFAOYSA-N 0.000 claims 1
- LCOPXFSCLUHKIK-UHFFFAOYSA-N 2-[3-ethoxy-5-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]acetic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)CC(=O)O LCOPXFSCLUHKIK-UHFFFAOYSA-N 0.000 claims 1
- LTRAWVGAFMVZJA-UHFFFAOYSA-N 2-[3-ethyl-5-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]acetic acid Chemical compound C(C)C1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)CC(=O)O LTRAWVGAFMVZJA-UHFFFAOYSA-N 0.000 claims 1
- WFSGCPHULXWDQH-UHFFFAOYSA-N 2-[4-[6-[2-(1,3-difluoronaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenyl]acetic acid Chemical compound FC1=C(C(=CC2=CC=CC=C12)F)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OCC WFSGCPHULXWDQH-UHFFFAOYSA-N 0.000 claims 1
- CYMAMJBPKACOFW-UHFFFAOYSA-N 2-[4-[6-[2-(1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenoxy]acetic acid Chemical compound S1C2=C(C=C1)C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(OCC(=O)O)C=C1)OCC CYMAMJBPKACOFW-UHFFFAOYSA-N 0.000 claims 1
- UUCYWGIIAPYHCU-UHFFFAOYSA-N 2-[4-[6-[2-(1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]propanoic acid Chemical compound S1C2=C(C=C1)C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)C(C(=O)O)C)CCC UUCYWGIIAPYHCU-UHFFFAOYSA-N 0.000 claims 1
- WCJYMQFBKGEDOR-UHFFFAOYSA-N 2-[4-[6-[2-(1-fluoro-3-methoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylphenyl]acetic acid Chemical compound FC1=C(C(=CC2=CC=CC=C12)OC)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)SC WCJYMQFBKGEDOR-UHFFFAOYSA-N 0.000 claims 1
- CWYWFLNZTJOBSJ-UHFFFAOYSA-N 2-[4-[6-[2-(3-chloro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]acetic acid Chemical compound ClC=1C2=C(SC=1)C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC(F)(F)F CWYWFLNZTJOBSJ-UHFFFAOYSA-N 0.000 claims 1
- VXDPSOYFFHSQGO-UHFFFAOYSA-N 2-[4-[6-[2-(3-chloro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenyl]acetic acid Chemical compound ClC=1C2=C(SC=1)C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OCC VXDPSOYFFHSQGO-UHFFFAOYSA-N 0.000 claims 1
- DETVNRSUMJMDJM-UHFFFAOYSA-N 2-[4-[6-[2-(3-chloro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound ClC=1C2=C(SC=1)C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC DETVNRSUMJMDJM-UHFFFAOYSA-N 0.000 claims 1
- FJFGWNLYPCBFMC-UHFFFAOYSA-N 2-[4-[6-[2-(3-cyano-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenyl]acetic acid Chemical compound C(#N)C=1C(=C(C2=CC=CC=C2C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OCC FJFGWNLYPCBFMC-UHFFFAOYSA-N 0.000 claims 1
- AWYAHNDCVXJZCW-UHFFFAOYSA-N 2-[4-[6-[2-(3-cyanonaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenoxy]acetic acid Chemical compound C(#N)C=1C(=CC2=CC=CC=C2C=1)CCNC1=CC(=NC=N1)C1=CC(=C(OCC(=O)O)C=C1)OCC AWYAHNDCVXJZCW-UHFFFAOYSA-N 0.000 claims 1
- BTRHEFWWSJRNDO-UHFFFAOYSA-N 2-[4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]acetic acid Chemical compound COC=1C(=C(C2=CC=CC=C2C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC(F)(F)F BTRHEFWWSJRNDO-UHFFFAOYSA-N 0.000 claims 1
- QUDACYPUEONKBE-UHFFFAOYSA-N 2-[4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-propoxyphenyl]acetic acid Chemical compound COC=1C(=C(C2=CC=CC=C2C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OCCC QUDACYPUEONKBE-UHFFFAOYSA-N 0.000 claims 1
- QGZGABCPDXOEFG-UHFFFAOYSA-N 2-[4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound COC=1C(=C(C2=CC=CC=C2C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC QGZGABCPDXOEFG-UHFFFAOYSA-N 0.000 claims 1
- JEVHFPBTMKYICG-UHFFFAOYSA-N 2-[4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)phenyl]acetic acid Chemical compound FC1=C(C=CC=2SC=CC=21)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CC(C)C JEVHFPBTMKYICG-UHFFFAOYSA-N 0.000 claims 1
- IWOCAFGNODRAFC-UHFFFAOYSA-N 2-[4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methoxyphenyl]acetic acid Chemical compound FC1=C(C=CC=2SC=CC=21)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC IWOCAFGNODRAFC-UHFFFAOYSA-N 0.000 claims 1
- JSKVKOYQKFWJQR-UHFFFAOYSA-N 2-[4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propan-2-yloxyphenyl]acetic acid Chemical compound FC1=C(C=CC=2SC=CC=21)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC(C)C JSKVKOYQKFWJQR-UHFFFAOYSA-N 0.000 claims 1
- LLYRJRALJQBTSY-UHFFFAOYSA-N 2-[4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propoxyphenyl]acetic acid Chemical compound FC1=C(C=CC=2SC=CC=21)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OCCC LLYRJRALJQBTSY-UHFFFAOYSA-N 0.000 claims 1
- QHYJKLDAUACQES-UHFFFAOYSA-N 2-[4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound FC1=C(C=CC=2SC=CC=21)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC QHYJKLDAUACQES-UHFFFAOYSA-N 0.000 claims 1
- VGGZQFWGLQQXBO-UHFFFAOYSA-N 2-[4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]propanoic acid Chemical compound FC1=C(C=CC=2SC=CC=21)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)C(C(=O)O)C)CCC VGGZQFWGLQQXBO-UHFFFAOYSA-N 0.000 claims 1
- RHVNZHGAMTWCOY-UHFFFAOYSA-N 2-[4-[6-[2-(5-fluoro-7-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound FC1=C(C(=CC=2OCCOC=21)OC)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC RHVNZHGAMTWCOY-UHFFFAOYSA-N 0.000 claims 1
- CZQZAVTTZZHDKE-UHFFFAOYSA-N 2-[4-[6-[2-(5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]acetic acid Chemical compound CC1=C(C=CC=2OCCOC=21)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC(F)(F)F CZQZAVTTZZHDKE-UHFFFAOYSA-N 0.000 claims 1
- WVPODQMRNVCTKW-UHFFFAOYSA-N 2-[4-[6-[2-(6-cyano-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenyl]acetic acid Chemical compound C(#N)C=1C(=CC2=C(SC=C2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OCC WVPODQMRNVCTKW-UHFFFAOYSA-N 0.000 claims 1
- NWXGTHGEFJPZHB-UHFFFAOYSA-N 2-[4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)phenyl]acetic acid Chemical compound C(C)OC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CC(C)C NWXGTHGEFJPZHB-UHFFFAOYSA-N 0.000 claims 1
- UZDGIEGKBPCJNN-UHFFFAOYSA-N 2-[4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]acetic acid Chemical compound C(C)OC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC(F)(F)F UZDGIEGKBPCJNN-UHFFFAOYSA-N 0.000 claims 1
- PJAVWTALLQROJF-UHFFFAOYSA-N 2-[4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-ethylphenyl]acetic acid Chemical compound C(C)OC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CC PJAVWTALLQROJF-UHFFFAOYSA-N 0.000 claims 1
- DXVZOMRIHCEBSC-UHFFFAOYSA-N 2-[4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-propan-2-yloxyphenyl]acetic acid Chemical compound C(C)OC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC(C)C DXVZOMRIHCEBSC-UHFFFAOYSA-N 0.000 claims 1
- YVEWUMCNAAKNPT-UHFFFAOYSA-N 2-[4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound C(C)OC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC YVEWUMCNAAKNPT-UHFFFAOYSA-N 0.000 claims 1
- GHWLYLGQWWYRJJ-UHFFFAOYSA-N 2-[4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]propanoic acid Chemical compound C(C)OC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)C(C(=O)O)C)CCC GHWLYLGQWWYRJJ-UHFFFAOYSA-N 0.000 claims 1
- FYCKRGZITQGCTB-UHFFFAOYSA-N 2-[4-[6-[2-(6-ethynyl-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-methoxyphenyl]acetic acid Chemical compound C(#C)C=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC FYCKRGZITQGCTB-UHFFFAOYSA-N 0.000 claims 1
- GGAFKVAFENDFHT-UHFFFAOYSA-N 2-[4-[6-[2-(6-ethynyl-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound C(#C)C=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC GGAFKVAFENDFHT-UHFFFAOYSA-N 0.000 claims 1
- XXPPVJWFZYXWHU-UHFFFAOYSA-N 2-[4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylphenyl]acetic acid Chemical compound COC=1C(=CC2=C(SC=C2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)SC XXPPVJWFZYXWHU-UHFFFAOYSA-N 0.000 claims 1
- HDEUHGQNCJNWHU-UHFFFAOYSA-N 2-[4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propoxyphenyl]acetic acid Chemical compound COC=1C(=CC2=C(SC=C2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OCCC HDEUHGQNCJNWHU-UHFFFAOYSA-N 0.000 claims 1
- FTNCYRRIOOXEHH-UHFFFAOYSA-N 2-[4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound COC=1C(=CC2=C(SC=C2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC FTNCYRRIOOXEHH-UHFFFAOYSA-N 0.000 claims 1
- MAXRIXJBQZHUPL-UHFFFAOYSA-N 2-[4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)phenyl]acetic acid Chemical compound C(C(C)C)C1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OC)CC(=O)O MAXRIXJBQZHUPL-UHFFFAOYSA-N 0.000 claims 1
- POHWSRURIUATQJ-UHFFFAOYSA-N 2-[4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]acetic acid Chemical compound COC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC(F)(F)F POHWSRURIUATQJ-UHFFFAOYSA-N 0.000 claims 1
- OZAVUIAJFZGUFO-UHFFFAOYSA-N 2-[4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound COC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC OZAVUIAJFZGUFO-UHFFFAOYSA-N 0.000 claims 1
- HEKVBGOPOAVMNK-UHFFFAOYSA-N 2-[4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methoxyphenyl]acetic acid Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC HEKVBGOPOAVMNK-UHFFFAOYSA-N 0.000 claims 1
- HUHOWRUPSMRWRA-UHFFFAOYSA-N 2-[4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC HUHOWRUPSMRWRA-UHFFFAOYSA-N 0.000 claims 1
- DJKYWLCSVDTOSU-UHFFFAOYSA-N 2-[4-[6-[2-(7-fluoro-6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)phenyl]acetic acid Chemical compound FC1=C(C(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CC(C)C)OC DJKYWLCSVDTOSU-UHFFFAOYSA-N 0.000 claims 1
- RCQLSZKOPNUTHA-UHFFFAOYSA-N 2-[4-[6-[2-(7-fluoro-6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methoxyphenyl]acetic acid Chemical compound FC1=C(C(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC)OC RCQLSZKOPNUTHA-UHFFFAOYSA-N 0.000 claims 1
- BMHLCVJKWYONCC-UHFFFAOYSA-N 2-[4-[6-[2-(7-fluoro-6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound FC1=C(C(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC)OC BMHLCVJKWYONCC-UHFFFAOYSA-N 0.000 claims 1
- HQRDCCBZVDPPDG-UHFFFAOYSA-N 2-[4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]acetic acid Chemical compound COC=1C(=C(C2=C(OCCO2)C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)OC(F)(F)F HQRDCCBZVDPPDG-UHFFFAOYSA-N 0.000 claims 1
- AVAJCTVAWDELLV-UHFFFAOYSA-N 2-[4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]-2-propan-2-yloxyphenyl]acetic acid Chemical compound C(C)(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1OC)C)CC(=O)O AVAJCTVAWDELLV-UHFFFAOYSA-N 0.000 claims 1
- RAANGDDPXJZYII-UHFFFAOYSA-N 2-[4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound COC=1C(=C(C2=C(OCCO2)C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC RAANGDDPXJZYII-UHFFFAOYSA-N 0.000 claims 1
- QJSWCATUHKBVEG-UHFFFAOYSA-N 2-[4-[6-[2-(7-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]-2-propylphenyl]acetic acid Chemical compound CC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CC(=O)O)CCC QJSWCATUHKBVEG-UHFFFAOYSA-N 0.000 claims 1
- QSCMRDNTQOTNBV-UHFFFAOYSA-N 2-[5-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-3-propylthiophen-2-yl]acetic acid Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)CC(=O)O)CCC QSCMRDNTQOTNBV-UHFFFAOYSA-N 0.000 claims 1
- XEGLUZOUSYJIJH-UHFFFAOYSA-N 2-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-1H-indole-4-carboxylic acid Chemical compound CC1=C(C=CC2=CC=CC=C12)CCNC1=CC(=NC=N1)C=1NC=2C=CC=C(C=2C=1)C(=O)O XEGLUZOUSYJIJH-UHFFFAOYSA-N 0.000 claims 1
- KSZDDPISQLNXJN-UHFFFAOYSA-N 2-butoxy-4-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(CCC)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C KSZDDPISQLNXJN-UHFFFAOYSA-N 0.000 claims 1
- CNNIMQRCDWTLNO-UHFFFAOYSA-N 2-butoxy-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(CCC)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F CNNIMQRCDWTLNO-UHFFFAOYSA-N 0.000 claims 1
- LHOUZODIUKAIFU-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(1-fluoro-3-methoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)F LHOUZODIUKAIFU-UHFFFAOYSA-N 0.000 claims 1
- GWWXWVAYYHEIDQ-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(2,3-dihydro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SCC2)C=C1 GWWXWVAYYHEIDQ-UHFFFAOYSA-N 0.000 claims 1
- HQOLBQPWQNORNX-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(3-ethoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1OCC HQOLBQPWQNORNX-UHFFFAOYSA-N 0.000 claims 1
- CWBMYCXCXKOGNU-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)C CWBMYCXCXKOGNU-UHFFFAOYSA-N 0.000 claims 1
- MBXZCLXUNJAXBD-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(SC=C2)C=C1)F MBXZCLXUNJAXBD-UHFFFAOYSA-N 0.000 claims 1
- DERDQFJUHHJXQD-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(4-methyl-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(SC=C2)C=C1)C DERDQFJUHHJXQD-UHFFFAOYSA-N 0.000 claims 1
- UBUIPCBNPVTFGV-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(5-methoxy-1-benzofuran-6-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(C=CO2)C=C1OC UBUIPCBNPVTFGV-UHFFFAOYSA-N 0.000 claims 1
- QRDIUCZGYZKVJO-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OCC QRDIUCZGYZKVJO-UHFFFAOYSA-N 0.000 claims 1
- WDSYTYBJWKDPMF-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(6-methoxy-1,3-benzodioxol-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCO2)C=C1OC WDSYTYBJWKDPMF-UHFFFAOYSA-N 0.000 claims 1
- DEAIQTLBCJQVKE-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(6-methoxy-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1)OC DEAIQTLBCJQVKE-UHFFFAOYSA-N 0.000 claims 1
- RXFFRYWHDVRCHG-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1OC RXFFRYWHDVRCHG-UHFFFAOYSA-N 0.000 claims 1
- FAYNKQNLDNFMIP-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OC FAYNKQNLDNFMIP-UHFFFAOYSA-N 0.000 claims 1
- LLSZBAJHHYLNRH-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(6-methoxy-4-methyl-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1C)OC LLSZBAJHHYLNRH-UHFFFAOYSA-N 0.000 claims 1
- JPDNWUUJYUXEBT-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(6-methylsulfanyl-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1SC JPDNWUUJYUXEBT-UHFFFAOYSA-N 0.000 claims 1
- AGJBGGSWYPZVPC-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F AGJBGGSWYPZVPC-UHFFFAOYSA-N 0.000 claims 1
- BZXQVOZQFFSBIS-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(7-fluoro-6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1OC)F BZXQVOZQFFSBIS-UHFFFAOYSA-N 0.000 claims 1
- ABHZOEHNABPFDK-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1OC)C ABHZOEHNABPFDK-UHFFFAOYSA-N 0.000 claims 1
- MFOOZJXOEXXDOC-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(7-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1C MFOOZJXOEXXDOC-UHFFFAOYSA-N 0.000 claims 1
- JMNBTDXEMOTBSE-UHFFFAOYSA-N 2-cyclopropyloxy-4-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C JMNBTDXEMOTBSE-UHFFFAOYSA-N 0.000 claims 1
- SKOVWBCRMJSNDI-UHFFFAOYSA-N 2-cyclopropyloxy-4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)C SKOVWBCRMJSNDI-UHFFFAOYSA-N 0.000 claims 1
- QEBCOVPPNBSBOS-UHFFFAOYSA-N 2-cyclopropyloxy-4-[6-[2-(5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1)C QEBCOVPPNBSBOS-UHFFFAOYSA-N 0.000 claims 1
- HTFHXZCNDIIUHP-UHFFFAOYSA-N 2-cyclopropyloxy-4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OCC HTFHXZCNDIIUHP-UHFFFAOYSA-N 0.000 claims 1
- QREKNDLOZHKQDU-UHFFFAOYSA-N 2-cyclopropyloxy-4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OC QREKNDLOZHKQDU-UHFFFAOYSA-N 0.000 claims 1
- AOOFSMKMDOGXPN-UHFFFAOYSA-N 2-cyclopropyloxy-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F AOOFSMKMDOGXPN-UHFFFAOYSA-N 0.000 claims 1
- MDALHCSNERXKLO-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(1-fluoro-3-methoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)F MDALHCSNERXKLO-UHFFFAOYSA-N 0.000 claims 1
- FKHWTMXAEWFULH-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C FKHWTMXAEWFULH-UHFFFAOYSA-N 0.000 claims 1
- WRKGVSOPOQILRX-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(3-ethoxy-1-fluoronaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OCC)F WRKGVSOPOQILRX-UHFFFAOYSA-N 0.000 claims 1
- KCIIZFRKZIOIJE-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(3-ethoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OCC)C KCIIZFRKZIOIJE-UHFFFAOYSA-N 0.000 claims 1
- GCTUHBBRFXBEML-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(3-ethynylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1C#C GCTUHBBRFXBEML-UHFFFAOYSA-N 0.000 claims 1
- JTMJYENFSAFDLD-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)C JTMJYENFSAFDLD-UHFFFAOYSA-N 0.000 claims 1
- QNZZPZOPTCRVLV-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(SC=C2)C=C1)F QNZZPZOPTCRVLV-UHFFFAOYSA-N 0.000 claims 1
- HYQIMQSMFGHKKH-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(4-fluoro-3-methoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C(=C1OC)F HYQIMQSMFGHKKH-UHFFFAOYSA-N 0.000 claims 1
- COSRONUEIINCOD-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(4-methyl-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(SC=C2)C=C1)C COSRONUEIINCOD-UHFFFAOYSA-N 0.000 claims 1
- GDXZAZVGADPIMT-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(5-fluoro-7-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1OC)F GDXZAZVGADPIMT-UHFFFAOYSA-N 0.000 claims 1
- JWMLZTPKAOGUTR-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1)C JWMLZTPKAOGUTR-UHFFFAOYSA-N 0.000 claims 1
- SYXYQCPUVDHUOA-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(6-ethoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1OCC SYXYQCPUVDHUOA-UHFFFAOYSA-N 0.000 claims 1
- WEECDNMGAKMXEP-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OCC WEECDNMGAKMXEP-UHFFFAOYSA-N 0.000 claims 1
- GUGMMRZXZNPXJR-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(6-ethynyl-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1C#C GUGMMRZXZNPXJR-UHFFFAOYSA-N 0.000 claims 1
- NNNAFIKSZZKLBH-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(6-fluoro-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1)F NNNAFIKSZZKLBH-UHFFFAOYSA-N 0.000 claims 1
- FQPRBKFSHGIFNI-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(6-methoxy-1,3-benzodioxol-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCO2)C=C1OC FQPRBKFSHGIFNI-UHFFFAOYSA-N 0.000 claims 1
- NIPRXIDXHSFUAA-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(6-methoxy-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1)OC NIPRXIDXHSFUAA-UHFFFAOYSA-N 0.000 claims 1
- AXKXISNPOIGAIU-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1OC AXKXISNPOIGAIU-UHFFFAOYSA-N 0.000 claims 1
- CTRFBIYKJHSSKP-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OC CTRFBIYKJHSSKP-UHFFFAOYSA-N 0.000 claims 1
- XRHWVEKWSRAYCQ-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(6-methoxy-4-methyl-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1C)OC XRHWVEKWSRAYCQ-UHFFFAOYSA-N 0.000 claims 1
- VNXYLVCARUDCIC-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(6-methyl-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1C VNXYLVCARUDCIC-UHFFFAOYSA-N 0.000 claims 1
- QISYYUXNJPDLLW-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-N-(2-hydroxyethyl)benzamide Chemical class C(C)OC1=C(C(=O)NCCO)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F QISYYUXNJPDLLW-UHFFFAOYSA-N 0.000 claims 1
- YHMSTNLGNNTAES-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F YHMSTNLGNNTAES-UHFFFAOYSA-N 0.000 claims 1
- ZIUCFTPLIQYRSS-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(7-fluoro-6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1OC)F ZIUCFTPLIQYRSS-UHFFFAOYSA-N 0.000 claims 1
- UVKXTESVTFELMF-UHFFFAOYSA-N 2-ethoxy-4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1OC)C UVKXTESVTFELMF-UHFFFAOYSA-N 0.000 claims 1
- RKXJAZBLSKJUSJ-UHFFFAOYSA-N 2-ethyl-4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)C1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)C RKXJAZBLSKJUSJ-UHFFFAOYSA-N 0.000 claims 1
- PMHWHHKJKNDWAA-UHFFFAOYSA-N 2-ethyl-4-[6-[2-(5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)C1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1)C PMHWHHKJKNDWAA-UHFFFAOYSA-N 0.000 claims 1
- BXYDWWULQCGATC-UHFFFAOYSA-N 2-ethyl-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)C1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F BXYDWWULQCGATC-UHFFFAOYSA-N 0.000 claims 1
- DVHLEKZUYBTODF-UHFFFAOYSA-N 2-ethylsulfanyl-4-[6-[2-(6-methoxy-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)SC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1)OC DVHLEKZUYBTODF-UHFFFAOYSA-N 0.000 claims 1
- XZWNRLMKHSTXOK-UHFFFAOYSA-N 2-ethylsulfanyl-4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)SC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OC XZWNRLMKHSTXOK-UHFFFAOYSA-N 0.000 claims 1
- STMIAYFDVBKIMI-UHFFFAOYSA-N 2-ethylsulfanyl-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)SC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F STMIAYFDVBKIMI-UHFFFAOYSA-N 0.000 claims 1
- JYQSPWXBVLOMHZ-UHFFFAOYSA-N 2-fluoro-4-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-6-propylbenzoic acid Chemical compound FC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C)CCC JYQSPWXBVLOMHZ-UHFFFAOYSA-N 0.000 claims 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims 1
- RZHVLCNTOJOZCG-UHFFFAOYSA-N 3-(2-hydroxyethoxy)-5-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound OCCOC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C)C(=O)O RZHVLCNTOJOZCG-UHFFFAOYSA-N 0.000 claims 1
- HBUDCDIHGSCFJA-UHFFFAOYSA-N 3-[2-ethoxy-4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]phenoxy]propanoic acid Chemical compound C(C)OC1=C(OCCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)C HBUDCDIHGSCFJA-UHFFFAOYSA-N 0.000 claims 1
- MLSFULIDTYJAPK-UHFFFAOYSA-N 3-[2-ethoxy-4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenoxy]propanoic acid Chemical compound C(C)OC1=C(OCCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(SC=C2)C=C1)F MLSFULIDTYJAPK-UHFFFAOYSA-N 0.000 claims 1
- WFKWPAJAHUQKBJ-UHFFFAOYSA-N 3-[2-ethoxy-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenoxy]propanoic acid Chemical compound C(C)OC1=C(OCCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F WFKWPAJAHUQKBJ-UHFFFAOYSA-N 0.000 claims 1
- XZKQEYLRWNFALU-UHFFFAOYSA-N 3-[3-ethoxy-5-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]propanoic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C)CCC(=O)O XZKQEYLRWNFALU-UHFFFAOYSA-N 0.000 claims 1
- SVXKRYPNLTUXMH-UHFFFAOYSA-N 3-[3-ethoxy-5-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]propanoic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)CCC(=O)O SVXKRYPNLTUXMH-UHFFFAOYSA-N 0.000 claims 1
- KTQOLHDXXKWHCJ-UHFFFAOYSA-N 3-[4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methoxyphenoxy]propanoic acid Chemical compound FC1=C(C=CC=2SC=CC=21)CCNC1=CC(=NC=N1)C1=CC(=C(OCCC(=O)O)C=C1)OC KTQOLHDXXKWHCJ-UHFFFAOYSA-N 0.000 claims 1
- ZUCUZISYQXJTNG-UHFFFAOYSA-N 3-[4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methoxyphenoxy]propanoic acid Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(OCCC(=O)O)C=C1)OC ZUCUZISYQXJTNG-UHFFFAOYSA-N 0.000 claims 1
- MINCHVTZSUOFML-UHFFFAOYSA-N 3-[4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]phenyl]-4-hydroxycyclobut-3-ene-1,2-dione Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C=1C(C(C=1O)=O)=O MINCHVTZSUOFML-UHFFFAOYSA-N 0.000 claims 1
- JATSMPFWFRWGQM-UHFFFAOYSA-N 3-ethoxy-5-[6-(2-naphthalen-2-ylethylamino)pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1)C(=O)O JATSMPFWFRWGQM-UHFFFAOYSA-N 0.000 claims 1
- QFCUERBGGZZLNX-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(1-ethynylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C#C)C(=O)O QFCUERBGGZZLNX-UHFFFAOYSA-N 0.000 claims 1
- KZNWYIRFLTWFAK-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(1-fluoro-3-methoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)F)C(=O)O KZNWYIRFLTWFAK-UHFFFAOYSA-N 0.000 claims 1
- JWVHNSZQYTVMAZ-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(1-fluoronaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)F)C(=O)O JWVHNSZQYTVMAZ-UHFFFAOYSA-N 0.000 claims 1
- YDNRTVDEGLKKIA-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(1-methylindol-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C2C=CN(C2=CC=1)C)C(=O)O YDNRTVDEGLKKIA-UHFFFAOYSA-N 0.000 claims 1
- SBRRWTXTQUQHNB-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(1-methylindol-6-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC=C2C=CN(C2=C1)C)C(=O)O SBRRWTXTQUQHNB-UHFFFAOYSA-N 0.000 claims 1
- KQGKCBAKUSXYLS-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-N-methylsulfonylthiophene-2-carboxamide Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C)C(=O)NS(=O)(=O)C KQGKCBAKUSXYLS-UHFFFAOYSA-N 0.000 claims 1
- GBIVLBIVINFOEE-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-N-sulfamoylthiophene-2-carboxamide Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C)C(=O)NS(N)(=O)=O GBIVLBIVINFOEE-UHFFFAOYSA-N 0.000 claims 1
- KYJGUOFPWNZANJ-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C)C(=O)O KYJGUOFPWNZANJ-UHFFFAOYSA-N 0.000 claims 1
- FQVUYUAYLHTQEO-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(1H-indol-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C2C=CNC2=CC=1)C(=O)O FQVUYUAYLHTQEO-UHFFFAOYSA-N 0.000 claims 1
- NNPGDNSFSJVMDO-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(1H-indol-6-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC=C2C=CNC2=C1)C(=O)O NNPGDNSFSJVMDO-UHFFFAOYSA-N 0.000 claims 1
- UKMQJWONYQZQGW-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(3-ethoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1OCC)C(=O)O UKMQJWONYQZQGW-UHFFFAOYSA-N 0.000 claims 1
- LLVHCXCMJZLBAP-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1OC)C)C(=O)O LLVHCXCMJZLBAP-UHFFFAOYSA-N 0.000 claims 1
- CUAYUQNCBCQDHC-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(3-methoxy-5,6,7,8-tetrahydronaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC=2CCCCC=2C=C1OC)C(=O)O CUAYUQNCBCQDHC-UHFFFAOYSA-N 0.000 claims 1
- GWEIYCPSANDHOA-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(3-methoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1OC)C(=O)O GWEIYCPSANDHOA-UHFFFAOYSA-N 0.000 claims 1
- AEEZGBRAUTZKJH-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(3-methyl-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2C)C=C1)C(=O)O AEEZGBRAUTZKJH-UHFFFAOYSA-N 0.000 claims 1
- VQGROINTIJGVQZ-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(3-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1C)C(=O)O VQGROINTIJGVQZ-UHFFFAOYSA-N 0.000 claims 1
- MDKTVSWFYZEBSP-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(3-propan-2-yloxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1OC(C)C)C(=O)O MDKTVSWFYZEBSP-UHFFFAOYSA-N 0.000 claims 1
- KYKZPBGOBWSCOS-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound CCOc1cc(sc1C(O)=O)-c1cc(NCCc2ccc3sccc3c2F)ncn1 KYKZPBGOBWSCOS-UHFFFAOYSA-N 0.000 claims 1
- XLBYBDNACPCWJS-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(4-fluoro-7-methoxy-2-methyl-1-benzothiophen-6-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C(C2=C(SC(=C2)C)C=1OC)F)C(=O)O XLBYBDNACPCWJS-UHFFFAOYSA-N 0.000 claims 1
- ITWCVWZTYHAOAM-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(4-methyl-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(SC=C2)C=C1)C)C(=O)O ITWCVWZTYHAOAM-UHFFFAOYSA-N 0.000 claims 1
- TWKPPUXGUQDCBK-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(5-fluoro-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C(=C1)F)C(=O)O TWKPPUXGUQDCBK-UHFFFAOYSA-N 0.000 claims 1
- AONJJKBADCIWHY-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(5-fluoroquinolin-6-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C(=C2C=CC=NC2=CC=1)F)C(=O)O AONJJKBADCIWHY-UHFFFAOYSA-N 0.000 claims 1
- LYDZXEASJPKRPO-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(5-methoxy-1-benzothiophen-6-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(SC=C2)C=1)OC)C(=O)O LYDZXEASJPKRPO-UHFFFAOYSA-N 0.000 claims 1
- ONJDLUSGIVWLKO-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(5-methyl-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C(=C1)C)C(=O)O ONJDLUSGIVWLKO-UHFFFAOYSA-N 0.000 claims 1
- XUWLSGYMLLTFMO-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OCC)C(=O)O XUWLSGYMLLTFMO-UHFFFAOYSA-N 0.000 claims 1
- QUQRZHFNHYXHJE-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-fluoro-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1)F)C(=O)O QUQRZHFNHYXHJE-UHFFFAOYSA-N 0.000 claims 1
- PJXJVURYUNWLCC-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-fluoro-1-methylindol-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C2C=CN(C2=CC=1F)C)C(=O)O PJXJVURYUNWLCC-UHFFFAOYSA-N 0.000 claims 1
- LMTQGEQSRKWIDN-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-fluoroisoquinolin-7-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C=C2C=CN=CC2=C1)F)C(=O)O LMTQGEQSRKWIDN-UHFFFAOYSA-N 0.000 claims 1
- UPKJNXIOVPQKFU-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-methoxy-1,3-benzodioxol-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCO2)C=C1OC)C(=O)O UPKJNXIOVPQKFU-UHFFFAOYSA-N 0.000 claims 1
- JNHVGJWLDZYRQA-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-methoxy-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1)OC)C(=O)O JNHVGJWLDZYRQA-UHFFFAOYSA-N 0.000 claims 1
- XJQDKWNHCQJOEE-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1OC)C(=O)O XJQDKWNHCQJOEE-UHFFFAOYSA-N 0.000 claims 1
- QWTGZQKMQUCRNK-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1OC)C(=O)O QWTGZQKMQUCRNK-UHFFFAOYSA-N 0.000 claims 1
- APBDZCQWNLUOMG-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-methoxy-4-methyl-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(C=CO2)C=1C)OC)C(=O)O APBDZCQWNLUOMG-UHFFFAOYSA-N 0.000 claims 1
- XZQKUBPYZKKPSP-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-methyl-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C=C1C)C(=O)O XZQKUBPYZKKPSP-UHFFFAOYSA-N 0.000 claims 1
- TULMQLAADWBOES-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-methylsulfanyl-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1SC)C(=O)O TULMQLAADWBOES-UHFFFAOYSA-N 0.000 claims 1
- HYWANWNZJSTACB-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)C(=O)O HYWANWNZJSTACB-UHFFFAOYSA-N 0.000 claims 1
- AGNFMNCZDDITDA-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-fluoro-4-methyl-2,3-dihydro-1,4-benzoxazin-6-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C(=CC2=C(N(CCO2)C)C=1)F)C(=O)O AGNFMNCZDDITDA-UHFFFAOYSA-N 0.000 claims 1
- AGEFDSYCXUWVFD-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-fluoro-6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1OC)F)C(=O)O AGEFDSYCXUWVFD-UHFFFAOYSA-N 0.000 claims 1
- JRXWJHLXEJQPLX-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-fluoroquinolin-6-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C2C=CC=NC2=CC=1F)C(=O)O JRXWJHLXEJQPLX-UHFFFAOYSA-N 0.000 claims 1
- ISMPMWOMHZFDGJ-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-methoxy-3,4-dihydro-2H-1,5-benzodioxepin-8-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCCO2)C=C1OC)C(=O)O ISMPMWOMHZFDGJ-UHFFFAOYSA-N 0.000 claims 1
- WANPTDGIMBYSQS-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-methyl-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)C)C(=O)O WANPTDGIMBYSQS-UHFFFAOYSA-N 0.000 claims 1
- BJPCSSOJXAKEOT-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-methyl-1-benzothiophen-6-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=CC2=C(SC=C2)C=1C)C(=O)O BJPCSSOJXAKEOT-UHFFFAOYSA-N 0.000 claims 1
- KTIVZNOZWNPPJE-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(OCCO2)C=C1C)C(=O)O KTIVZNOZWNPPJE-UHFFFAOYSA-N 0.000 claims 1
- FPNHVYYVSHVLAH-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(8-fluoronaphthalen-2-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(C=CC=C2C=C1)F)C(=O)O FPNHVYYVSHVLAH-UHFFFAOYSA-N 0.000 claims 1
- FVFUWMVSEWRGPF-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(8-methylquinolin-7-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC=C2C=CC=NC2=C1C)C(=O)O FVFUWMVSEWRGPF-UHFFFAOYSA-N 0.000 claims 1
- PVKGNUQJNNEFGJ-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-[7-(trifluoromethyl)-1-benzothiophen-5-yl]ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)C(F)(F)F)C(=O)O PVKGNUQJNNEFGJ-UHFFFAOYSA-N 0.000 claims 1
- WPZCRZARQXOISQ-UHFFFAOYSA-N 3-ethyl-5-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)C1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)C(=O)O WPZCRZARQXOISQ-UHFFFAOYSA-N 0.000 claims 1
- VXLFDONXBQYYCL-UHFFFAOYSA-N 4-[6-[2-(1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound O1C=CC2=C1C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC VXLFDONXBQYYCL-UHFFFAOYSA-N 0.000 claims 1
- SINXPQNSTFIZAV-UHFFFAOYSA-N 4-[6-[2-(1-benzofuran-6-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound O1C=CC2=C1C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC SINXPQNSTFIZAV-UHFFFAOYSA-N 0.000 claims 1
- XKZLBWHRCIKWJY-UHFFFAOYSA-N 4-[6-[2-(1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-cyclobutyloxybenzoic acid Chemical compound S1C2=C(C=C1)C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OC1CCC1 XKZLBWHRCIKWJY-UHFFFAOYSA-N 0.000 claims 1
- GTALJRIEDLWJGP-UHFFFAOYSA-N 4-[6-[2-(1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound S1C2=C(C=C1)C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC GTALJRIEDLWJGP-UHFFFAOYSA-N 0.000 claims 1
- HNEOASWOVRIWSY-UHFFFAOYSA-N 4-[6-[2-(1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound S1C2=C(C=C1)C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC HNEOASWOVRIWSY-UHFFFAOYSA-N 0.000 claims 1
- KYVVKDNEYWKCJX-UHFFFAOYSA-N 4-[6-[2-(1-fluoro-3-methoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound FC1=C(C(=CC2=CC=CC=C12)OC)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC KYVVKDNEYWKCJX-UHFFFAOYSA-N 0.000 claims 1
- TTWLBGORPXPLTF-UHFFFAOYSA-N 4-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound CC(C)Cc1cc(ccc1C(O)=O)-c1cc(NCCc2ccc3ccccc3c2C)ncn1 TTWLBGORPXPLTF-UHFFFAOYSA-N 0.000 claims 1
- SYALDWKBYSGPKJ-UHFFFAOYSA-N 4-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-propoxybenzoic acid Chemical compound CC1=C(C=CC2=CC=CC=C12)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCCC SYALDWKBYSGPKJ-UHFFFAOYSA-N 0.000 claims 1
- OCCRSJDEVRGFMG-UHFFFAOYSA-N 4-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-propylbenzoic acid Chemical compound CC1=C(C=CC2=CC=CC=C12)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CCC OCCRSJDEVRGFMG-UHFFFAOYSA-N 0.000 claims 1
- MPGXNJDPZUVONC-UHFFFAOYSA-N 4-[6-[2-(2,3-dihydro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound S1C2=C(CC1)C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC MPGXNJDPZUVONC-UHFFFAOYSA-N 0.000 claims 1
- VMHXPGMDCKXUIQ-UHFFFAOYSA-N 4-[6-[2-(3-chloro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-cyclobutyloxybenzoic acid Chemical compound ClC=1C2=C(SC=1)C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OC1CCC1 VMHXPGMDCKXUIQ-UHFFFAOYSA-N 0.000 claims 1
- YQZGHONFTGCJEP-UHFFFAOYSA-N 4-[6-[2-(3-chloro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound ClC=1C2=C(SC=1)C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC YQZGHONFTGCJEP-UHFFFAOYSA-N 0.000 claims 1
- UMXACHISYWENBX-UHFFFAOYSA-N 4-[6-[2-(3-chloro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound ClC=1C2=C(SC=1)C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC UMXACHISYWENBX-UHFFFAOYSA-N 0.000 claims 1
- CHQHWMOINGMRCG-UHFFFAOYSA-N 4-[6-[2-(3-cyano-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound C(#N)C=1C2=C(SC=1)C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC CHQHWMOINGMRCG-UHFFFAOYSA-N 0.000 claims 1
- CZPFMIBKJLHIRI-UHFFFAOYSA-N 4-[6-[2-(3-cyano-1-fluoronaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound C(#N)C=1C(=C(C2=CC=CC=C2C=1)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC CZPFMIBKJLHIRI-UHFFFAOYSA-N 0.000 claims 1
- IOXKQBDGMPHMQH-UHFFFAOYSA-N 4-[6-[2-(3-cyano-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound C(#N)C=1C(=C(C2=CC=CC=C2C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC IOXKQBDGMPHMQH-UHFFFAOYSA-N 0.000 claims 1
- WEHZFQOOOUBYBM-UHFFFAOYSA-N 4-[6-[2-(3-cyano-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound C(#N)C=1C(=C(C2=CC=CC=C2C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC WEHZFQOOOUBYBM-UHFFFAOYSA-N 0.000 claims 1
- MMINYOUMKYOCMQ-UHFFFAOYSA-N 4-[6-[2-(3-cyanonaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound C(#N)C=1C(=CC2=CC=CC=C2C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC MMINYOUMKYOCMQ-UHFFFAOYSA-N 0.000 claims 1
- CZVXYOGRNSDABL-UHFFFAOYSA-N 4-[6-[2-(3-ethoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound C(C)OC=1C(=C(C2=CC=CC=C2C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC CZVXYOGRNSDABL-UHFFFAOYSA-N 0.000 claims 1
- NAAUODAIWCFUOH-UHFFFAOYSA-N 4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound COC=1C(=C(C2=CC=CC=C2C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC NAAUODAIWCFUOH-UHFFFAOYSA-N 0.000 claims 1
- GNTMXTDCRUTDOS-UHFFFAOYSA-N 4-[6-[2-(3-methoxy-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-2-propylbenzoic acid Chemical compound COC=1C(=C(C2=CC=CC=C2C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CCC GNTMXTDCRUTDOS-UHFFFAOYSA-N 0.000 claims 1
- IDAOBUIYGNIKBD-UHFFFAOYSA-N 4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound FC1=C(C=CC=2SC=CC=21)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CC(C)C IDAOBUIYGNIKBD-UHFFFAOYSA-N 0.000 claims 1
- XCQBAQCTUFCDJW-UHFFFAOYSA-N 4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound FC1=C(C=CC=2SC=CC=21)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC XCQBAQCTUFCDJW-UHFFFAOYSA-N 0.000 claims 1
- QJTJTPXWRYDAEA-UHFFFAOYSA-N 4-[6-[2-(4-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylbenzoic acid Chemical compound FC1=C(C=CC=2SC=CC=21)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CCC QJTJTPXWRYDAEA-UHFFFAOYSA-N 0.000 claims 1
- GDXSKHNBJAIDTC-UHFFFAOYSA-N 4-[6-[2-(4-methyl-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound CC1=C(C=CC=2SC=CC=21)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC GDXSKHNBJAIDTC-UHFFFAOYSA-N 0.000 claims 1
- CBTXBZQMOBZUKW-UHFFFAOYSA-N 4-[6-[2-(5-methoxy-1-benzothiophen-6-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound COC1=CC2=C(SC=C2)C=C1CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC CBTXBZQMOBZUKW-UHFFFAOYSA-N 0.000 claims 1
- WFHQXFPZLWIGFN-UHFFFAOYSA-N 4-[6-[2-(6-cyano-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound C(#N)C=1C(=CC2=C(SC=C2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC WFHQXFPZLWIGFN-UHFFFAOYSA-N 0.000 claims 1
- YCYYNYACSXRMMR-UHFFFAOYSA-N 4-[6-[2-(6-cyano-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound C(#N)C=1C(=CC2=C(SC=C2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC YCYYNYACSXRMMR-UHFFFAOYSA-N 0.000 claims 1
- ITOALPSIXBLKJT-UHFFFAOYSA-N 4-[6-[2-(6-cyano-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-cyclobutyloxybenzoic acid Chemical compound C(#N)C=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OC1CCC1 ITOALPSIXBLKJT-UHFFFAOYSA-N 0.000 claims 1
- YYBZAJFVXITMOT-UHFFFAOYSA-N 4-[6-[2-(6-cyano-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound C(#N)C=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC YYBZAJFVXITMOT-UHFFFAOYSA-N 0.000 claims 1
- DGMBHORWAPZLIX-UHFFFAOYSA-N 4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound C(C)OC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CC(C)C DGMBHORWAPZLIX-UHFFFAOYSA-N 0.000 claims 1
- RQCLFVFDWLTNRG-UHFFFAOYSA-N 4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-ethylbenzoic acid Chemical compound C(C)OC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CC RQCLFVFDWLTNRG-UHFFFAOYSA-N 0.000 claims 1
- WZROZRSVHFNJTA-UHFFFAOYSA-N 4-[6-[2-(6-ethoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound C(C)OC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC WZROZRSVHFNJTA-UHFFFAOYSA-N 0.000 claims 1
- ZWLWYTOYUYAYDY-UHFFFAOYSA-N 4-[6-[2-(6-fluoro-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound FC1=CC2=C(C=CO2)C=C1CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC ZWLWYTOYUYAYDY-UHFFFAOYSA-N 0.000 claims 1
- SXTXDANEZWXFEY-UHFFFAOYSA-N 4-[6-[2-(6-methoxy-1,3-benzodioxol-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound COC=1C(=CC2=C(OCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC SXTXDANEZWXFEY-UHFFFAOYSA-N 0.000 claims 1
- PTCGDNMBBCTENY-UHFFFAOYSA-N 4-[6-[2-(6-methoxy-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound COC1=CC2=C(C=CO2)C=C1CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC PTCGDNMBBCTENY-UHFFFAOYSA-N 0.000 claims 1
- UALFDMHZNUQCEW-UHFFFAOYSA-N 4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound COC=1C(=CC2=C(SC=C2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC UALFDMHZNUQCEW-UHFFFAOYSA-N 0.000 claims 1
- PXMVDYHDDVJHDL-UHFFFAOYSA-N 4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylbenzoic acid Chemical compound COC=1C(=CC2=C(SC=C2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CCC PXMVDYHDDVJHDL-UHFFFAOYSA-N 0.000 claims 1
- LGRVEFHTNFISFH-UHFFFAOYSA-N 4-[6-[2-(6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound COC=1C(=CC2=C(SC=C2)C=1)CCNC1=CC(=NC=N1)C1=CC=C(C(=O)O)C=C1 LGRVEFHTNFISFH-UHFFFAOYSA-N 0.000 claims 1
- GKROMWPMMFYBHC-UHFFFAOYSA-N 4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound COc1cc2OCCOc2cc1CCNc1cc(ncn1)-c1ccc(C(O)=O)c(CC(C)C)c1 GKROMWPMMFYBHC-UHFFFAOYSA-N 0.000 claims 1
- YJKUYFOIQRWMSZ-UHFFFAOYSA-N 4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound COC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC YJKUYFOIQRWMSZ-UHFFFAOYSA-N 0.000 claims 1
- BKRDOIHWFJDQSK-UHFFFAOYSA-N 4-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-2-propylbenzoic acid Chemical compound COC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CCC BKRDOIHWFJDQSK-UHFFFAOYSA-N 0.000 claims 1
- MSXBTECIKPMTIO-UHFFFAOYSA-N 4-[6-[2-(6-methyl-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound CC=1C(=CC2=C(SC=C2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC MSXBTECIKPMTIO-UHFFFAOYSA-N 0.000 claims 1
- XNEGWYSYKJPLEM-UHFFFAOYSA-N 4-[6-[2-(7-chloro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound ClC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC XNEGWYSYKJPLEM-UHFFFAOYSA-N 0.000 claims 1
- XIVDCHPUVUISEC-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2,6-dimethylphenol Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=C1)C)O)C XIVDCHPUVUISEC-UHFFFAOYSA-N 0.000 claims 1
- DCNSKVKDSVDHEX-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropoxy)benzoic acid Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC(C)C DCNSKVKDSVDHEX-UHFFFAOYSA-N 0.000 claims 1
- QXLXJPFQYNTZGD-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CC(C)C QXLXJPFQYNTZGD-UHFFFAOYSA-N 0.000 claims 1
- NRMVFOMKXOCLKE-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC NRMVFOMKXOCLKE-UHFFFAOYSA-N 0.000 claims 1
- IZUQRWSOWOIRCK-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylbenzamide Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)N)C=C1)CCC IZUQRWSOWOIRCK-UHFFFAOYSA-N 0.000 claims 1
- NRSVPUSXKMVHDJ-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylbenzoic acid Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CCC NRSVPUSXKMVHDJ-UHFFFAOYSA-N 0.000 claims 1
- WYQGKVJZJGOPNM-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound FC1=C(C(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CC(C)C)OC WYQGKVJZJGOPNM-UHFFFAOYSA-N 0.000 claims 1
- KNBBRDVOGZHDAH-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound FC1=C(C(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC)OC KNBBRDVOGZHDAH-UHFFFAOYSA-N 0.000 claims 1
- RJGAYNSXANSMPZ-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-6-methoxy-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-2-propylbenzoic acid Chemical compound FC1=C(C(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CCC)OC RJGAYNSXANSMPZ-UHFFFAOYSA-N 0.000 claims 1
- CVMFUYFBWFFWSG-UHFFFAOYSA-N 4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound COC=1C(=C(C2=C(OCCO2)C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC CVMFUYFBWFFWSG-UHFFFAOYSA-N 0.000 claims 1
- KOKCLTURFFEUNH-UHFFFAOYSA-N 4-[6-[2-(7-methoxy-5-methyl-2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]-2-propan-2-yloxybenzoic acid Chemical compound C(C)(C)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=C(OCCO2)C=C1OC)C KOKCLTURFFEUNH-UHFFFAOYSA-N 0.000 claims 1
- PZMGQSOOWROROS-UHFFFAOYSA-N 4-[6-[2-[6-(difluoromethoxy)-2,3-dihydro-1,4-benzodioxin-7-yl]ethylamino]pyrimidin-4-yl]-2-methylsulfanylbenzoic acid Chemical compound FC(OC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC)F PZMGQSOOWROROS-UHFFFAOYSA-N 0.000 claims 1
- IBCFJUCXUAASPT-UHFFFAOYSA-N 4-ethoxy-2-[6-[2-(1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-1,3-thiazole-5-carboxylic acid Chemical compound C(C)OC=1N=C(SC=1C(=O)O)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C IBCFJUCXUAASPT-UHFFFAOYSA-N 0.000 claims 1
- XKPWOIORAXMGKA-UHFFFAOYSA-N 5-[6-[2-(1,2-benzothiazol-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound S1N=CC2=C1C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC XKPWOIORAXMGKA-UHFFFAOYSA-N 0.000 claims 1
- DRXCVMISCQHEER-UHFFFAOYSA-N 5-[6-[2-(1,3-benzodioxol-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound O1COC2=C1C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC DRXCVMISCQHEER-UHFFFAOYSA-N 0.000 claims 1
- NTXFSUNJHDWOLJ-UHFFFAOYSA-N 5-[6-[2-(1,3-benzothiazol-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound S1C=NC2=C1C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC NTXFSUNJHDWOLJ-UHFFFAOYSA-N 0.000 claims 1
- BYUPHRPSRLPHLJ-UHFFFAOYSA-N 5-[6-[2-(1,3-benzothiazol-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound S1C=NC2=C1C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC BYUPHRPSRLPHLJ-UHFFFAOYSA-N 0.000 claims 1
- YEZRIDROQLHOHE-UHFFFAOYSA-N 5-[6-[2-(1,3-benzoxazol-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound O1C=NC2=C1C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC YEZRIDROQLHOHE-UHFFFAOYSA-N 0.000 claims 1
- PLEJWETXNWRZIZ-UHFFFAOYSA-N 5-[6-[2-(1,3-difluoronaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC1=C(C(=CC2=CC=CC=C12)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC PLEJWETXNWRZIZ-UHFFFAOYSA-N 0.000 claims 1
- XVXCUOUYNVTZGF-UHFFFAOYSA-N 5-[6-[2-(1,3-dihydro-2-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C1OCC2=CC(=CC=C12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC XVXCUOUYNVTZGF-UHFFFAOYSA-N 0.000 claims 1
- WTFGBMREWPOJHU-UHFFFAOYSA-N 5-[6-[2-(1-aminonaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound NC1=C(C=CC2=CC=CC=C12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC WTFGBMREWPOJHU-UHFFFAOYSA-N 0.000 claims 1
- WQMPZGHPNSRJHI-UHFFFAOYSA-N 5-[6-[2-(1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound O1C=CC2=C1C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC WQMPZGHPNSRJHI-UHFFFAOYSA-N 0.000 claims 1
- JJTKZODUZXUWPF-UHFFFAOYSA-N 5-[6-[2-(1-benzofuran-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound O1C=CC2=C1C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC JJTKZODUZXUWPF-UHFFFAOYSA-N 0.000 claims 1
- VZOKBBYHDUUBSU-UHFFFAOYSA-N 5-[6-[2-(1-benzothiophen-5-yl)ethylamino]-2-methylpyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound S1C2=C(C=C1)C=C(C=C2)CCNC1=CC(=NC(=N1)C)C1=CC(=C(S1)C(=O)O)OCC VZOKBBYHDUUBSU-UHFFFAOYSA-N 0.000 claims 1
- LFTPFIIZQSQMRK-UHFFFAOYSA-N 5-[6-[2-(1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-1-benzofuran-2-carboxylic acid Chemical compound S1C2=C(C=C1)C=C(C=C2)CCNC1=CC(=NC=N1)C=1C=CC2=C(C=C(O2)C(=O)O)C=1 LFTPFIIZQSQMRK-UHFFFAOYSA-N 0.000 claims 1
- AKAKKBQDQJBVJW-UHFFFAOYSA-N 5-[6-[2-(1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound S1C2=C(C=C1)C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC AKAKKBQDQJBVJW-UHFFFAOYSA-N 0.000 claims 1
- JSQKRADYNMJLKV-UHFFFAOYSA-N 5-[6-[2-(1-benzothiophen-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound S1C2=C(C=C1)C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC JSQKRADYNMJLKV-UHFFFAOYSA-N 0.000 claims 1
- ZAROYLBMYOHJHM-UHFFFAOYSA-N 5-[6-[2-(1-chloronaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=C(C=CC2=CC=CC=C12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC ZAROYLBMYOHJHM-UHFFFAOYSA-N 0.000 claims 1
- ZTECZJFKIBRXGR-UHFFFAOYSA-N 5-[6-[2-(1-cyanonaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C1=C(C=CC2=CC=CC=C12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC ZTECZJFKIBRXGR-UHFFFAOYSA-N 0.000 claims 1
- DZJUKYOFSJRWAF-UHFFFAOYSA-N 5-[6-[2-(1-ethenylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=C(C2=CC=CC=C2C=C1)C=C)C(=O)O DZJUKYOFSJRWAF-UHFFFAOYSA-N 0.000 claims 1
- SPPRFSUTTIKJHP-UHFFFAOYSA-N 5-[6-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound O1CCOC2=C1C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC SPPRFSUTTIKJHP-UHFFFAOYSA-N 0.000 claims 1
- SZUIFRWSLVDMBV-UHFFFAOYSA-N 5-[6-[2-(2,3-dihydro-1-benzofuran-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound O1CCC2=C1C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC SZUIFRWSLVDMBV-UHFFFAOYSA-N 0.000 claims 1
- NMIBPSRZKMSKKX-UHFFFAOYSA-N 5-[6-[2-(2,3-dihydro-1-benzofuran-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound O1CCC2=C1C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC NMIBPSRZKMSKKX-UHFFFAOYSA-N 0.000 claims 1
- UIWVPULCNSSHAE-UHFFFAOYSA-N 5-[6-[2-(2,3-dihydro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound CCOc1cc(sc1C(O)=O)-c1cc(NCCc2ccc3SCCc3c2)ncn1 UIWVPULCNSSHAE-UHFFFAOYSA-N 0.000 claims 1
- OLADIOUMCVLFSP-UHFFFAOYSA-N 5-[6-[2-(2,3-dihydro-1H-inden-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C2CCCC2=CC=1)C(=O)O OLADIOUMCVLFSP-UHFFFAOYSA-N 0.000 claims 1
- DWJWWZWAQWRYRC-UHFFFAOYSA-N 5-[6-[2-(3,4-dihydro-2H-chromen-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound O1CCCC2=CC(=CC=C12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC DWJWWZWAQWRYRC-UHFFFAOYSA-N 0.000 claims 1
- BZNRJAMDHANADX-UHFFFAOYSA-N 5-[6-[2-(3,4-dihydro-2H-chromen-7-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound O1CCCC2=CC=C(C=C12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC BZNRJAMDHANADX-UHFFFAOYSA-N 0.000 claims 1
- MBYUKPKBBYZSNZ-UHFFFAOYSA-N 5-[6-[2-(3-chloronaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC=1C(=CC2=CC=CC=C2C=1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC MBYUKPKBBYZSNZ-UHFFFAOYSA-N 0.000 claims 1
- WHCUIBAJJDKKPD-UHFFFAOYSA-N 5-[6-[2-(3-cyano-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1C2=C(SC=1)C=CC(=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC WHCUIBAJJDKKPD-UHFFFAOYSA-N 0.000 claims 1
- YERUFQGUQWRRPR-UHFFFAOYSA-N 5-[6-[2-(3-cyano-1-methylnaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1C(=C(C2=CC=CC=C2C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC YERUFQGUQWRRPR-UHFFFAOYSA-N 0.000 claims 1
- XSBQQEICJDANOJ-UHFFFAOYSA-N 5-[6-[2-(4,5-difluoro-7-methoxy-2-methyl-1-benzofuran-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC1=C(C(=C(C2=C1C=C(O2)C)OC)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)F XSBQQEICJDANOJ-UHFFFAOYSA-N 0.000 claims 1
- WWQVLVKBHUUPOB-UHFFFAOYSA-N 5-[6-[2-(4-chloro-3-methoxynaphthalen-2-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=C(C(=CC2=CC=CC=C12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)OC WWQVLVKBHUUPOB-UHFFFAOYSA-N 0.000 claims 1
- HTOGBFSYDYPJTQ-UHFFFAOYSA-N 5-[6-[2-(4-chloro-7-methylquinolin-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=CC=NC2=CC(=C(C=C12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C HTOGBFSYDYPJTQ-UHFFFAOYSA-N 0.000 claims 1
- PVYBPKUCEYFMSW-UHFFFAOYSA-N 5-[6-[2-(5,7-difluoroquinolin-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC1=C2C=CC=NC2=CC(=C1CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)F PVYBPKUCEYFMSW-UHFFFAOYSA-N 0.000 claims 1
- CSYFUVCWRGQNQP-UHFFFAOYSA-N 5-[6-[2-(5,8-difluoroquinolin-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC1=C2C=CC=NC2=C(C=C1CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)F CSYFUVCWRGQNQP-UHFFFAOYSA-N 0.000 claims 1
- DOAOROGGKBSQLI-UHFFFAOYSA-N 5-[6-[2-(5-chloro-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=CC(=CC2=C1OCCO2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC DOAOROGGKBSQLI-UHFFFAOYSA-N 0.000 claims 1
- HPUYWIGMUJQEDD-UHFFFAOYSA-N 5-[6-[2-(6-cyano-1,3-benzodioxol-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1C(=CC2=C(OCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC HPUYWIGMUJQEDD-UHFFFAOYSA-N 0.000 claims 1
- AWJJUFORPPOWCJ-UHFFFAOYSA-N 5-[6-[2-(6-cyano-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC AWJJUFORPPOWCJ-UHFFFAOYSA-N 0.000 claims 1
- NPCVQVUBEPQEMD-UHFFFAOYSA-N 5-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-1-benzofuran-2-carboxylic acid Chemical compound COC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C=1C=CC2=C(C=C(O2)C(=O)O)C=1 NPCVQVUBEPQEMD-UHFFFAOYSA-N 0.000 claims 1
- GVBCXNNCRNDEBH-UHFFFAOYSA-N 5-[6-[2-(7-chloro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC GVBCXNNCRNDEBH-UHFFFAOYSA-N 0.000 claims 1
- DFHOFCSLFCLXPU-UHFFFAOYSA-N 5-[6-[2-(7-chloro-8-fluoroquinolin-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=C(C=C2C=CC=NC2=C1F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC DFHOFCSLFCLXPU-UHFFFAOYSA-N 0.000 claims 1
- LWQYODWKSMDLCR-UHFFFAOYSA-N 5-[6-[2-(7-chloro-8-methylquinolin-6-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=C(C=C2C=CC=NC2=C1C)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC LWQYODWKSMDLCR-UHFFFAOYSA-N 0.000 claims 1
- GKJZUAWCWCGUMF-UHFFFAOYSA-N 5-[6-[2-(7-fluoro-1-methyl-3,4-dihydro-2H-quinolin-6-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound FC1=C(C=C2CCCN(C2=C1)C)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F GKJZUAWCWCGUMF-UHFFFAOYSA-N 0.000 claims 1
- ZJAKHDAYDBGGOV-UHFFFAOYSA-N 5-[6-[2-(7-fluoroisoquinolin-6-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound FC1=C(C=C2C=CN=CC2=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F ZJAKHDAYDBGGOV-UHFFFAOYSA-N 0.000 claims 1
- KYCMYEUFAVNDJR-UHFFFAOYSA-N 5-[6-[2-[3-(difluoromethoxy)naphthalen-2-yl]ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC(OC=1C(=CC2=CC=CC=C2C=1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)F KYCMYEUFAVNDJR-UHFFFAOYSA-N 0.000 claims 1
- RTBDVJRVXJUKSU-UHFFFAOYSA-N 5-[6-[2-[6-(difluoromethoxy)-1,3-benzodioxol-5-yl]ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC(OC=1C(=CC2=C(OCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)F RTBDVJRVXJUKSU-UHFFFAOYSA-N 0.000 claims 1
- JTXVMVLUIAZHBO-UHFFFAOYSA-N 5-[6-[2-[6-(difluoromethoxy)-2,3-dihydro-1,4-benzodioxin-7-yl]ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC(OC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)F JTXVMVLUIAZHBO-UHFFFAOYSA-N 0.000 claims 1
- MWKKGHIWYSBVSW-UHFFFAOYSA-N 6-[6-[2-(1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]-1-benzofuran-2-carboxylic acid Chemical compound S1C2=C(C=C1)C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC2=C(C=C(O2)C(=O)O)C=C1 MWKKGHIWYSBVSW-UHFFFAOYSA-N 0.000 claims 1
- ZNYNPXULRWRBCZ-UHFFFAOYSA-N 6-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-1-benzofuran-2-carboxylic acid Chemical compound COC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC2=C(C=C(O2)C(=O)O)C=C1 ZNYNPXULRWRBCZ-UHFFFAOYSA-N 0.000 claims 1
- JVBFXQNDPIFYKM-UHFFFAOYSA-N 6-[6-[2-(6-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl)ethylamino]pyrimidin-4-yl]-1-benzofuran-3-carboxylic acid Chemical compound COC=1C(=CC2=C(OCCO2)C=1)CCNC1=CC(=NC=N1)C1=CC2=C(C(=CO2)C(=O)O)C=C1 JVBFXQNDPIFYKM-UHFFFAOYSA-N 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- ZZBXEAKSGATTQW-UHFFFAOYSA-N C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1)C1=NOC(N1)=O Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC1=CC2=CC=CC=C2C=C1)C1=NOC(N1)=O ZZBXEAKSGATTQW-UHFFFAOYSA-N 0.000 claims 1
- XTQVIFWACFZFDJ-UHFFFAOYSA-N C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C2C=CC=NC2=CC=1)C1=NOC(N1)=O Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCC=1C=C2C=CC=NC2=CC=1)C1=NOC(N1)=O XTQVIFWACFZFDJ-UHFFFAOYSA-N 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 1
- MGEUVFYKWDCQFL-UHFFFAOYSA-N FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C1=NOC(N1)=O Chemical compound FC1=CC(=CC2=C1SC=C2)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C1=NOC(N1)=O MGEUVFYKWDCQFL-UHFFFAOYSA-N 0.000 claims 1
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- BOWYQHCFTNADQJ-UHFFFAOYSA-N OC1=CN=NO1 Chemical compound OC1=CN=NO1 BOWYQHCFTNADQJ-UHFFFAOYSA-N 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- PMXJZZCLJHTWBP-UHFFFAOYSA-N S1C2=C(C=C1)C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C1=NOC(N1)=O)OCC Chemical compound S1C2=C(C=C1)C=C(C=C2)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C1=NOC(N1)=O)OCC PMXJZZCLJHTWBP-UHFFFAOYSA-N 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- ZOPWXLDONFDKQC-UHFFFAOYSA-N methyl 2-cyclopropyloxy-4-[6-[2-(7-fluoro-1-benzothiophen-5-yl)ethylamino]pyrimidin-4-yl]benzoate Chemical compound COC(C1=C(C=C(C=C1)C1=NC=NC(=C1)NCCC1=CC2=C(SC=C2)C(=C1)F)OC1CC1)=O ZOPWXLDONFDKQC-UHFFFAOYSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000004550 quinolin-6-yl group Chemical group N1=CC=CC2=CC(=CC=C12)* 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (15)
1. Spoj, naznačen time, da je predstavljen formulom (I)
[image]
za uporabu u liječenju raka, gdje se spomenuti rak liječi pomoću modulacije imunosnog odgovora koji sadrži reaktivaciju imunosnog sustava u tumoru;
pri čemu se spomenuti spoj opcionalno upotrebljava u kombinaciji s jednim ili više kemoterapijskih sredstava i / ili s radioterapijom i / ili sa ciljanom terapijom;
pri čemu u spojevima formule (I):
prsten (A) u odlomku:
[image]
predstavlja aromatski 5-člani ili 6-člani prsten ili nearomatski 5-člani do 7-člani prsten, gdje je prsten (A) staljen s fenilnom skupinom, dok neovisno navedeni prsten (A) opcionalno sadrži jedan ili dva heteroatoma koji se neovisno biraju od dušika, kisika, i sumpora;
pri čemu je navedeni odlomak opcionalno supstituiran s (R1)n; gdje(R1)n predstavlja jedan, dva, tri ili četiri opcionalna supstituenta, dok se navedeni supstituenti R1 neovisno biraju od sljedećih: (C13)alkil, (C23)alkenil, (C23)alkinil, (C13)alkoksi, halogen, -S-(C13)alkil, (C13)fluoroalkil, (C13)fluoroalkoksi, cijano, okso, -NRN7RN8 gdje RN7 i RN8 neovisno predstavljaju vodik ili (C1-4)alkil;
R3 predstavlja vodik, metil ili trifluorometil;
R4a i R4b neovisno predstavljaju vodik, metil, ili R4a i R4b zajedno s ugljikovim atomom s kojim su vezani, predstavljaju cikloprop-1,1-diil skupinu;
R5a i R5b neovisno predstavljaju vodik, metil, ili R5a i R5b zajedno s ugljikovim atomom s kojim su vezani, predstavljaju cikloprop-1,1-diil skupinu;
Ar1 predstavlja
• fenil, ili 5-člani ili 6-člani heteroaril; gdje je navedeni fenil ili 5-člani ili 6-člani heteroaril neovisno monosupstituiran, disupstituiran ili trisupstituiran, dok se supstituenti neovisno biraju od sljedećih:
▪ (C1-6)alkil;
▪ (C1-4)alkoksi;
▪ (C1-3)fluoroalkil, gdje je navedeni (C1-3)fluoroalkil opcionalno supstituiran s hidroksi;
▪ (C1-3)fluoroalkoksi;
▪ halogen;
▪ cijano;
▪ (C3-6)cikloalkil, gdje je navedeni (C3-6)cikloalkil nesupstituiran ili monosupstituiran s amino;
▪ (C4-6)cikloalkil koji sadrži prstenov atom kisika, gdje je navedeni (C4-6)cikloalkil koji sadrži prstenov atom kisika nesupstituiran ili monosupstituiran s hidroksi;
▪ (C3-6)cikloalkil-oksi;
▪ hidroksi;
▪ -X1-CO-RO1, gdje
‣ X1 predstavlja direktnu vezu, (C1-3)alkilen, -O-(C1-3)alkilen-*, -NH-(C1-3)alkilen-*, -S-CH2-*, -CF2-, –CH=CH-, eten-1,1-diil, –C≡C-, -NH-CO-*, -CO-, ili (C3-5)cikloalkilen; gdje zvjezdice označavaju vezu koja je povezana sa skupinom -CO-RO1; i
‣ RO1 predstavlja
• -OH;
• -O-(C1-4)alkil;
• -NH-SO2-RS3 gdje RS3 predstavlja (C1-4)alkil, (C3-6)cikloalkil gdje (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C3-6)cikloalkil-(C1-3)alkilen gdje
(C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C1-3)fluoroalkil, ili -NH2;
• -O-CH2-CO-RO4, gdje RO4 predstavlja hidroksi, ili (C1-4)alkoksi, ili -N[(C1-4)alkil]2;
• -O-CH2-O-CO-RO5, gdje RO5 predstavlja (C1-4)alkil ili (C1-4)alkoksi;
• -O-CH2-CH2-N[(C1-4)alkil]2; ili
• (5-metil-2-okso-[1,3]dioksol-4-il)-metiloksi-;
▪ -CO-CH2-OH;
▪
[image]
;
▪ 2-hidroksi-3,4-diokso-ciklobut-1-enil;
▪ hidroksi-(C1-4)alkil;
▪ dihidroksi-(C2-4)alkil;
▪ hidroksi-(C2-4)alkoksi;
▪ (C1-4)alkoksi-(C2-4)alkoksi;
▪ -(CH2)r-CO-NRN3RN4 gdje r predstavlja cijeli broj 0 ili 1; i gdje RN3 i RN4 neovisno predstavljaju vodik, (C1-4)alkil, hidroksi-(C2-4)alkil, (C1-3)alkoksi-(C2-4)alkil, ili hidroksi;
▪ -X2-NRN1RN2, gdje X2 predstavlja -(CH2)m-, gdje m predstavlja cijeli broj 0 ili 1; ili X2 predstavlja -O-CH2-CH2-*, pri čemu zvjezdica označava vezu koja je povezana sa skupinom -NRN1RN2; i gdje
‣ RN1 i RN2 neovisno predstavljaju vodik, (C1-4)alkil, (C1-4)alkoksi-(C2-4)alkil, (C3-6)cikloalkil, ili (C2-3)fluoroalkil;
‣ ili RN1 neovisno predstavlja vodik ili (C1-4)alkil, i RN2 neovisno predstavlja –CO-H,
–CO-(C1-3)alkil, –CO-(C1-3)alkilen-OH, ili –CO-O-(C1-3)alkil;
‣ ili RN1 i RN2 zajedno s dušikom s kojim su vezani, tvore 4-člani, 5-člani ili 6-člani zasićeni prsten koji opcionalno sadrži jedan prstenov atom kisika ili prstenov atom sumpora, pri čemu je navedeni prsten nesupstituiran, ili monosupstituiran s okso na prstenovom atomu ugljika, ili je disupstituiran s okso na prstenovom atomu sumpora;
▪ -NH-CO-NRN5RN6 gdje RN5 i RN6 neovisno predstavljaju vodik ili (C1-4)alkil;
▪ -SO2-RS1 gdje RS1 predstavlja hidroksi, (C1-4)alkil, ili -NRN7RN8 gdje RN7 i RN8 neovisno predstavljaju vodik ili (C1-3)alkil;
▪ -S-RS2 gdje RS2 predstavlja (C1-4)alkil, (C3-6)cikloalkil koji opcionalno sadrži jedan prstenov atom kisika;
▪ -(CH2)q-HET1, gdje q predstavlja cijeli broj 0, 1 ili 2; i gdje HET1 predstavlja 5-okso-4,5-dihidro-[1,2,4]oksadiazol-3-il, 3-okso-2,3-dihidro-[1,2,4]oksadiazol-5-il, ili 5-tiokso-4,5-dihidro-[1,2,4]oksadiazol-3-il;
▪ -(CH2)p-HET, gdje p predstavlja cijeli broj 0 ili 1; i gdje HET predstavlja 5-člani ili 6-člani heteroaril, pri čemu je navedeni 5-člani ili 6-člani heteroaril nesupstituiran, ili monosupstituiran ili disupstituiran, dok se supstituenti neovisno biraju od sljedećih: (C1-4)alkil, (C1-4)alkoksi, -COOH, hidroksi, hidroksi-(C1-3)alkil, (C3-5)cikloalkil koji opcionalno sadrži jedan prstenov atom kisika, ili -NRN9RN10 gdje RN9 i RN10 neovisno predstavljaju vodik, (C1-3)alkil, ili hidroksi-(C2-4)alkil;
• ili Ar1 predstavlja 8-člani do 10-člani biciklički heteroaril; pri čemu je navedeni 8-člani do 10-člani biciklički heteroaril neovisno nesupstituiran, monosupstituiran, ili disupstituiran, dok se supstituenti neovisno biraju od sljedećih: (C1-4)alkil; (C1-4)alkoksi; (C1-3)fluoroalkil; (C1-3)fluoroalkoksi; halogen; cijano; hidroksi, ili -(C0-3)alkilen-COORO2 gdje RO2 predstavlja vodik ili (C1-4)alkil;
• ili Ar1 predstavlja skupinu sljedeće strukture (Ar-III):
[image]
(Ar-III)
u kojoj prsten (B) predstavlja nearomatski 5-člani ili 6-člani prsten staljen s fenilnom skupinom, gdje prsten (B) sadrži jedan ili dva heteroatoma neovisno odabrana od dušika i kisika; pri čemu je navedeni prsten (B) neovisno nesupstituiran, monosupstituiran, ili disupstituiran, dok se supstituenti neovisno biraju od sljedećih: okso, (C1-6)alkil i -(C0-3)alkilen-COORO3 gdje RO3 predstavlja vodik ili (C1-3)alkil;
ili njegova farmaceutski prihvatljiva sol.
2. Spoj, naznačen time, da je predstavljen formulom (II)
[image]
pri čemu u spojevima formule (II)
prsten (A) u odlomku:
[image]
predstavlja aromatski 5-člani ili 6-člani prsten ili nearomatski 5-člani do 7-člani prsten, dok je prsten (A) staljen s fenilnom skupinom, gdje navedeni prsten (A) opcionalno sadrži jedan ili dva heteroatoma neovisno odabrana od dušika, kisika, i sumpora; pri čemu je navedeni odlomak opcionalno supstituiran s (R1)n; gdje(R1)n predstavlja jedan, dva, tri ili četiri opcionalna supstituenta, dok se navedeni supstituenti R1 neovisno biraju od sljedećih: (C13)alkil, (C23)alkenil, (C23)alkinil, (C13)alkoksi, halogen, -S-(C13)alkil, (C13)fluoroalkil, (C13)fluoroalkoksi, cijano, okso,
-NRN7RN8 gdje RN7 i RN8 neovisno predstavljaju vodik ili (C1-4)alkil;
R3 predstavlja vodik, ili metil;
Ar1 predstavlja
• fenilnu skupinu sljedeće strukture (Ar-I):
[image]
gdje
▪ Rp predstavlja
‣ (C4-6)cikloalkil koji sadrži prstenov atom kisika, gdje je navedeni (C4-6)cikloalkil koji sadrži prstenov atom kisika nesupstituiran ili monosupstituiran s hidroksi;
‣ hidroksi;
‣ -X1-CO-RO1, gdje
‣ X1 predstavlja direktnu vezu, (C1-3)alkilen, -O-(C1-3)alkilen-*, -NH-(C1-3)alkilen-*, -S-CH2-*, -CF2-, –CH=CH-, eten-1,1-diil, –C≡C-, -NH-CO-*, -CO-, ili (C3-5)cikloalkilen; pri čemu zvjezdice označavaju vezu koja je povezana s -CO-RO1 skupinom; i
‣ RO1 predstavlja
▪ -OH;
▪ -O-(C1-4)alkil;
▪ -NH-SO2-RS3 gdje RS3 predstavlja (C1-4)alkil, (C3-6)cikloalkil gdje (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C3-6)cikloalkil-(C1-3)alkilen gdje (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C1-3)fluoroalkil, ili -NH2;
▪ -O-CH2-CO-RO4, gdje RO4 predstavlja hidroksi, ili (C1-4)alkoksi, ili -N[(C1-4)alkil]2;
▪ -O-CH2-O-CO-RO5, gdje RO5 predstavlja (C1-4)alkil ili (C1-4)alkoksi;
▪ -O-CH2-CH2-N[(C1-4)alkil]2; ili
▪ (5-metil-2-okso-[1,3]dioksol-4-il)-metiloksi-;
‣
[image]
;
‣ 2-hidroksi-3,4-diokso-ciklobut-1-enil;
‣ hidroksi-(C1-4)alkil;
‣ hidroksi-(C2-4)alkoksi;
‣ -(CH2)r-CO-NRN3RN4 gdje r predstavlja cijeli broj 0 ili 1; i gdje RN3 i RN4 neovisno predstavljaju vodik, (C1-4)alkil, hidroksi-(C2-4)alkil, (C1-3)alkoksi-(C2-4)alkil, ili hidroksi;
‣ -NRN1RN2, gdje RN1 neovisno predstavlja vodik ili (C1-4)alkil, i RN2 neovisno predstavlja –CO-H,
–CO-(C1-3)alkil, ili –CO-(C1-3)alkilen-OH;
‣ -NH-CO-NRN5RN6 gdje RN5 i RN6 neovisno predstavljaju vodik ili (C1-4)alkil;
‣ -SO2-RS1 gdje RS1 predstavlja (C1-4)alkil, ili -NRN7RN8 gdje RN7 i RN8 neovisno predstavljaju vodik ili
(C1-3)alkil;
‣ -(CH2)q-HET1, gdje q predstavlja cijeli broj 0, 1 ili 2; i gdje HET1 predstavlja 5-okso-4,5-dihidro-[1,2,4]oksadiazol-3-il, 3-okso-2,3-dihidro-[1,2,4]oksadiazol-5-il, ili 5-tiokso-4,5-dihidro-[1,2,4]oksadiazol-3-il;
‣ -(CH2)p-HET, gdje p predstavlja cijeli broj 0 ili 1; i gdje HET predstavlja 5-člani heteroaril, pri čemu je navedeni 5-člani heteroaril nesupstituiran, ili monosupstituiran ili disupstituiran, dok se supstituenti neovisno biraju od sljedećih: (C1-4)alkil, (C1-4)alkoksi, -COOH, hidroksi, hidroksi-(C1-3)alkil,
(C3-5)cikloalkil koji opcionalno sadrži jedan prstenov atom kisika, ili -NRN9RN10 gdje RN9 i RN10 neovisno predstavljaju vodik, (C1-3)alkil, ili hidroksi-(C2-4)alkil;
▪ Rm1 predstavlja
‣ vodik;
‣ (C1-6)alkil;
‣ (C1-4)alkoksi;
‣ (C1-3)fluoroalkil;
‣ (C1-3)fluoroalkoksi;
‣ halogen;
‣ (C3-6)cikloalkil;
‣ (C3-6)cikloalkil-oksi;
‣ hidroksi;
‣ hidroksi-(C2-4)alkoksi;
‣ -X2-NRN1RN2, gdje X2 predstavlja direktnu vezu; ili X2 predstavlja -O-CH2-CH2-*, pri čemu zvjezdica označava vezu koja je povezana sa skupinom -NRN1RN2; i gdje RN1 i RN2 neovisno predstavljaju vodik, (C1-4)alkil, ili (C3-6)cikloalkil;
‣ -S-RS2 gdje RS2 predstavlja (C1-4)alkil, (C3-6)cikloalkil koji opcionalno sadrži jedan prstenov atom kisika;
▪ Rm2 predstavlja vodik, metil, fluoro, ili kloro; i
▪ Ro1 predstavlja vodik; ili, u slučaju da Rm2 predstavlja vodik, Ro1 predstavlja vodik ili fluoro;
• ili Ar1 predstavlja 5-članu heteroarilnu skupinu sljedeće strukture (Ar-II):
[image]
u kojoj
▪ Y predstavlja CR8 gdje R8 predstavlja vodik ili halogen; ili Y predstavlja N;
▪ R7 predstavlja
‣ (C4-6)cikloalkil koji sadrži prstenov atom kisika, gdje je navedeni (C4-6)cikloalkil koji sadrži prstenov atom kisika nesupstituiran ili monosupstituiran s hidroksi;
‣ -X1-CO-RO1, gdje
‣ X1 predstavlja direktnu vezu, (C1-3)alkilen, -O-(C1-3)alkilen-*, -NH-(C1-3)alkilen-*, -S-CH2-*, -CF2-, –CH=CH-, –C≡C-, -NH-CO-*, -CO-, ili (C3-5)cikloalkilen; pri čemu zvjezdice označavaju vezu koja je povezana sa skupinom -CO-RO1; i
‣ RO1 predstavlja
▪ -OH;
▪ -O-(C1-4)alkil;
▪ -NH-SO2-RS3 gdje RS3 predstavlja (C1-4)alkil, (C3-6)cikloalkil gdje (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C3-6)cikloalkil-(C1-3)alkilen gdje (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C1-3)fluoroalkil, ili -NH2;
▪ -O-CH2-CO-RO4, gdje RO4 predstavlja hidroksi, ili (C1-4)alkoksi, ili -N[(C1-4)alkil]2;
▪ -O-CH2-O-CO-RO5, gdje RO5 predstavlja (C1-4)alkil ili (C1-4)alkoksi;
▪ -O-CH2-CH2-N[(C1-4)alkil]2; ili
▪ (5-metil-2-okso-[1,3]dioksol-4-il)-metiloksi-;
‣
[image]
;
‣ 2-hidroksi-3,4-diokso-ciklobut-1-enil;
‣ hidroksi-(C1-4)alkil;
‣ hidroksi-(C2-4)alkoksi;
‣ -(CH2)r-CO-NRN3RN4 gdje r predstavlja cijeli broj 0 ili 1; i gdje RN3 i RN4 neovisno predstavljaju vodik, (C1-4)alkil, hidroksi-(C2-4)alkil, (C1-3)alkoksi-(C2-4)alkil, ili hidroksi;
‣ -NRN1RN2, gdje RN1 neovisno predstavlja vodik ili (C1-4)alkil, i RN2 neovisno predstavlja –CO-H, –CO-(C1-3)alkil, ili –CO-(C1-3)alkilen-OH;
‣ -NH-CO-NRN5RN6 gdje RN5 i RN6 neovisno predstavljaju vodik ili (C1-4)alkil;
‣ -SO2-RS1 gdje RS1 predstavlja (C1-4)alkil, ili -NRN7RN8 gdje RN7 i RN8 neovisno predstavljaju vodik ili (C1-3)alkil;
‣ -(CH2)q-HET1, gdje q predstavlja cijeli broj 0, 1 ili 2; i gdje HET1 predstavlja 5-okso-4,5-dihidro-[1,2,4]oksadiazol-3-il, 3-okso-2,3-dihidro-[1,2,4]oksadiazol-5-il, ili 5-tiokso-4,5-dihidro-[1,2,4]oksadiazol-3-il;
‣ -(CH2)p-HET, gdje p predstavlja cijeli broj 0 ili 1; i gdje HET predstavlja 5-člani heteroaril, pri čemu je navedeni 5-člani heteroaril nesupstituiran, ili monosupstituiran ili disupstituiran, dok se supstituenti neovisno biraju od sljedećih: (C1-4)alkil, (C1-4)alkoksi, -COOH, hidroksi, hidroksi-(C1-3)alkil, (C3-5)cikloalkil koji opcionalno sadrži jedan prstenov atom kisika, ili -NRN9RN10 gdje RN9 i RN10 neovisno predstavljaju vodik, (C1-3)alkil, ili hidroksi-(C2-4)alkil;
▪ R6 predstavlja
‣ (C1-6)alkil;
‣ (C1-4)alkoksi;
‣ (C1-3)fluoroalkil;
‣ (C1-3)fluoroalkoksi;
‣ halogen;
‣ hidroksi;
‣ (C3-6)cikloalkil;
‣ (C3-6)cikloalkil-oksi;
‣ hidroksi-(C2-4)alkoksi;
‣ -X2-NRN1RN2, gdje X2 predstavlja direktnu vezu; ili X2 predstavlja -O-CH2-CH2-*, pri čemu zvjezdica označava vezu koja je povezana sa skupinom -NRN1RN2; i gdje RN1 i RN2 neovisno predstavljaju vodik, (C1-4)alkil, ili (C3-6)cikloalkil;
‣ -S-RS2 gdje RS2 predstavlja (C1-4)alkil, (C3-6)cikloalkil koji opcionalno sadrži jedan prstenov atom kisika;
• ili Ar1 predstavlja 8-člani do 10-člani biciklički heteroaril; pri čemu je navedeni 8-člani do 10-člani biciklički heteroaril neovisno monosupstituiran s -(C0-3)alkilen-COORO2 gdje RO2 predstavlja vodik ili (C1-4)alkil;
• ili Ar1 predstavlja skupinu sljedeće strukture (Ar-III):
[image]
(Ar-III)
koja se bira od sljedećih: 2-okso-2,3-dihidro-benzooksazol-6-il, 3-metil-2-okso-2,3-dihidro-benzooksazol-5-il, 1-metil-3-okso-2,3-dihidro-1H-indazol-6-il, 2-okso-1,2,3,4-tetrahidro-kinazolin-6-il, 1-metil-2-okso-1,2,3,4-tetrahidro-kinazolin-6-il, 1-okso-1,2,3,4-tetrahidro-izokinolin-6-il, 1-metil-2-okso-1,2,3,4-tetrahidro-kinazolin-7-il, i 1-okso-1,2,3,4-tetrahidro-izokinolin-7-il;
ili njegova farmaceutski prihvatljiva sol.
3. Spoj prema patentnom zahtjevu 2; naznačen time, da Ar1 predstavlja skupinu odabranu od:
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
;
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
i
[image]
;
ili njihove farmaceutski prihvatljive soli.
4. Spoj prema patentnom zahtjevu 2; naznačen time, da Ar1 predstavlja skupinu odabranu od:
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
i
[image]
;
ili njihove farmaceutski prihvatljive soli.
5. Spoj prema bilo kojem od patentnih zahtjeva 2 do 4; naznačen time, da odlomak
[image]
predstavlja
▪ skupinu odabranu od sljedećih: benzofuranil, benzotiofenil, benzotiazolil, benzoizotiazolil, indolil, indazolil, naftil, kinolinil, i izokinolinil; dok je ta skupina neovisno nesupstituirana ili supstituirana s (R1)n; gdje(R1)n predstavlja jedan, dva, tri ili četiri supstituenta, dok se navedeni supstituenti R1 neovisno biraju od sljedećih: (C13)alkil, (C23)alkenil, (C23)alkinil, (C13)alkoksi, halogen, -S-(C13)alkil, (C13)fluoroalkil, (C13)fluoroalkoksi, cijano, ili -NRN7RN8 gdje RN7 i RN8 neovisno predstavljaju vodik ili (C1-4)alkil; ili
▪ skupinu odabranu od sljedećih: 2,3-dihidro-benzo[b]tiofenil, benzo[1,3]dioksolil, 1,3-dihidro-izobenzofuranil, 2,3-dihidro-benzofuranil, indanil, 5,6,7,8-tetrahidro-naftalenil, 2,3-dihidro-benzo[1,4]dioksinil, kromanil, 3,4-dihidro-2H-benzo[1,4]oksazinil, 1,2,3,4-tetrahidro-kinolinil, i 3,4-dihidro-2H-benzo[b][1,4]dioksepinil; gdje je ta skupina neovisno nesupstituirana, ili supstituirana s (R1)n; gdje(R1)n predstavlja jedan, dva ili tri supstituenta, dok se navedeni supstituenti R1 neovisno biraju od sljedećih: (C13)alkil, (C23)alkenil, (C23)alkinil, (C13)alkoksi, halogen, -S-(C13)alkil, (C13)fluoroalkil, (C13)fluoroalkoksi, cijano, okso, ili -NRN7RN8 gdje RN7 i RN8 neovisno predstavljaju vodik ili (C1-4)alkil;
ili njegova farmaceutski prihvatljiva sol.
6. Spoj prema bilo kojem od patentnih zahtjeva 2 do 4; naznačen time, da odlomak
[image]
predstavlja skupinu odabranu od sljedećih skupina a), b), c) i d), ili od sljedećih skupina e), f) i g):
a) benzotiofen-5-il, benzotiofen-6-il, 6-metil-benzotiofen-5-il, 3-metil-benzotiofen-5-il, 4-metil-benzotiofen-5-il, 6-metoksi-benzotiofen-5-il, 5-metoksi-benzotiofen-6-il, 6-cijano-benzotiofen-5-il, 3-cijano-benzotiofen-5-il, 6-etoksi-benzotiofen-5-il, 4-fluoro-7-metoksi-2-metil-benzotiofen-6-il, benzoizotiazol-5-il, benzotiazol-5-il, benzotiazol-6-il, benzofuran-5-il, benzofuran-6-il, 6-fluoro-benzofuran-5-il, 6-metoksi-benzofuran-5-il, 5-metoksi-benzofuran-6-il, 2-fluoro-5-metoksi-benzofuran-6-il, 6-metoksi-4-metil-benzofuran-5-il, 4,5-difluoro-7-metoksi-2-metil-benzofuran-6-il, benzooksazol-6-il, 1H-indol-5-il, 1H-indol-6-il, 1-metil-1H-indol-6-il, 1-metil-1H-indol-5-il, 6-fluoro-1-metil-1H-indol-5-il, 1,3-dimetil-1H-indol-5-il, 1-etil-1H-indol-6-il, ili 5-metoksi-1-metil-1H-indazol-6-il;
b) naftalen-2-il, 3-kloro-naftalen-2-il, 1-kloro-naftalen-2-il, 8-fluoro-naftalen-2-il, 1-fluoro-naftalen-2-il, 3-metil-naftalen-2-il, 1-metil-naftalen-2-il, 1-amino-naftalen-2-il, 3-etinil-naftalen-2-il, 1-etinil-naftalen-2-il, 1-vinil-naftalen-2-il, 1,3-difluoro-naftalen-2-il, 3-metoksi-naftalen-2-il, 3-cijano-naftalen-2-il, 1-cijano-naftalen-2-il, 3-metilamino-naftalen-2-il, 1-fluoro-3-metoksi-naftalen-2-il, 4-kloro-3-metoksi-naftalen-2-il, 4-fluoro-3-metoksi-naftalen-2-il, 3-etoksi-naftalen-2-il, 3-metoksi-1-metil-naftalen-2-il, 3-cijano-1-fluoro-naftalen-2-il, 3-cijano-1-metil-naftalen-2-il, 3-izopropoksi-naftalen-2-il, ili 3-difluorometoksi-naftalen-2-il;
c) kinolin-6-il, 6-fluoro-izokinolin-7-il, 7-fluoro-izokinolin-6-il, 5-fluoro-kinolin-6-il, 7-metil-kinolin-6-il, 8-metil-kinolin-7-il, 4-kloro-7-metil-kinolin-6-il, 7-kloro-8-metil-kinolin-6-il, 5,8-difluoro-kinolin-6-il, ili 7-kloro-8-fluoro-kinolin-6-il, 5,7-difluoro-kinolin-6-il;
d) 2,3-dihidro-benzo[b]tiofen-5-il, benzo[1,3]dioksol-5-il, 6-metoksi-benzo[1,3]dioksol-5-il, 6-cijano-benzo[1,3]dioksol-5-il, 6-kloro-2,2-difluoro-benzo[1,3]dioksol-5-il, 6-difluorometoksi-benzo[1,3]dioksol-5-il, 1,3-dihidro-izobenzofuran-5-il, 2,3-dihidro-benzofuran-5-il, 2,3-dihidro-benzofuran-6-il, indan-5-il, 3-metoksi-5,6,7,8-tetrahidro-naftalen-2-il, 2,3-dihidro-benzo[1,4]dioksin-6-il, 8-kloro-2,3-dihidro-benzo[1,4]dioksin-6-il, 8-fluoro-2,3-dihidro-benzo[1,4]dioksin-6-il, 8-metil-2,3-dihidro-benzo[1,4]dioksin-6-il, 7-metil-2,3-dihidro-benzo[1,4]dioksin-6-il, 7-metilsulfanil-2,3-dihidro-benzo[1,4]dioksin-6-il, 7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il, 7-cijano-2,3-dihidro-benzo[1,4]dioksin-6-il, 7-etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il, kroman-7-il, kroman-6-il, 6-kloro-3,4-dihidro-2H-benzo[1,4]oksazin-7-il, 7-fluoro-4-metil-3,4-dihidro-2H-benzo[1,4]oksazin-6-il, 7-fluoro-1-metil-1,2,3,4-tetrahidro-kinolin-6-il, 7-metoksi-1,2,3,4-tetrahidro-kinolin-6-il, 7-metoksi-1-metil-2-okso-1,2,3,4-tetrahidro-kinolin-6-il, ili 8-metoksi-3,4-dihidro-2H-benzo[b][1,4]dioksepin-7-il;
e) 7-metil-benzotiofen-5-il, 7-metil-benzotiofen-6-il, 4-fluoro-benzotiofen-5-il, 7-fluoro-benzotiofen-5-il, 7-kloro-benzotiofen-5-il, 3-kloro-benzotiofen-5-il, 3-kloro-7-fluoro-benzotiofen-5-il, 7-fluoro-6-metoksi-benzotiofen-5-il, 7-trifluorometil-benzotiofen-5-il;
f) 3-etoksi-1-fluoro-naftalen-2-il, 3-etoksi-1-metil-naftalen-2-il; i
g) 7-fluoro-2,3-dihidro-benzo[1,4]dioksin-6-il, 5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il, 7-etinil-2,3-dihidro-benzo[1,4]dioksin-6-il, 5-fluoro-7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il, 7-metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il, 7-difluorometoksi-2,3-dihidro-benzo[1,4]dioksin-6-il;
ili njegova farmaceutski prihvatljiva sol.
7. Spoj prema bilo kojem od patentnih zahtjeva 2 do 4; naznačen time, da odlomak
[image]
predstavlja skupinu odabranu od sljedećih skupina a), b), c) i d):
a) benzotiofen-5-il, 6-metil-benzotiofen-5-il, 4-metil-benzotiofen-5-il, 6-metoksi-benzotiofen-5-il, 5-metoksi-benzotiofen-6-il, 3-cijano-benzotiofen-5-il, 6-etoksi-benzotiofen-5-il, benzotiazol-5-il, benzofuran-5-il, 6-fluoro-benzofuran-5-il, 6-metoksi-benzofuran-5-il, 5-metoksi-benzofuran-6-il, 6-metoksi-4-metil-benzofuran-5-il, 1H-indol-5-il, ili 1H-indol-6-il;
b) 1-metil-naftalen-2-il, 1-etinil-naftalen-2-il, 3-metoksi-naftalen-2-il, 1-fluoro-3-metoksi-naftalen-2-il, 3-etoksi-naftalen-2-il, 3-metoksi-1-metil-naftalen-2-il, ili 3-cijano-1-metil-naftalen-2-il;
c) 7-kloro-8-fluoro-kinolin-6-il, ili 5,7-difluoro-kinolin-6-il;
d) 2,3-dihidro-benzo[b]tiofen-5-il, benzo[1,3]dioksol-5-il, 6-metoksi-benzo[1,3]dioksol-5-il, 6-cijano-benzo[1,3]dioksol-5-il, 6-difluorometoksi-benzo[1,3]dioksol-5-il, 7-metil-2,3-dihidro-benzo[1,4]dioksin-6-il, 7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il, 7-cijano-2,3-dihidro-benzo[1,4]dioksin-6-il, 7-etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il, ili 7-fluoro-4-metil-3,4-dihidro-2H-benzo[1,4]oksazin-6-il;
ili njegova farmaceutski prihvatljiva sol.
8. Spoj prema patentnom zahtjevu 2, naznačen time, da se bira iz skupine koju čine:
3-Etoksi-5-{6-[2-(3-metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(3-Cijano-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(1-fluoro-3-metoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-[6-(2-Benzo[b]tiofen-5-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(7-Cijano-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(6-metoksi-4-metil-benzofuran-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(3-metoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-[6-(2-Benzo[b]tiofen-6-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(6-metoksi-benzofuran-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(6-fluoro-benzofuran-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(5-metoksi-benzo[b]tiofen-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(2,3-Dihidro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(1-etinil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
4-{6-[2-(6-Metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
3-Etoksi-5-{6-[2-(4-metil-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(3-etoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(1H-indol-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
2-Ciklobutoksi-4-{6-[2-(1-fluoro-3-metoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
3-Etoksi-5-{6-[2-(7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(3-Cijano-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
4-{6-[2-(1-Metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-propil-benzojeva kiselina;
4-{6-[2-(1-Fluoro-3-metoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
3-Etoksi-5-{6-[2-(7-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(1H-indol-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(6-metil-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(8-fluoro-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-[6-(2-Benzo[b]tiofen-5-il-etilamino)-pirimidin-4-il]-benzofuran-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(7-etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(2,3-Dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(1-metil-1H-indol-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(5,7-Difluoro-kinolin-6-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(3-Difluorometoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-[6-(2-Benzofuran-6-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(3-metil-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-(2-Hidroksi-etoksi)-5-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(6-metoksi-benzo[1,3]dioksol-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-[6-(2-Benzofuran-5-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
4-{6-[2-(3-Cijano-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
(2-Etoksi-4-{6-[2-(6-etoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
5-[6-(2-Kroman-6-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
3-(3-Etoksi-5-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-propionska kiselina;
4-{6-[2-(3-Metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
5-{6-[2-(6-Cijano-benzo[1,3]dioksol-5-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(2,3-Dihidro-benzofuran-6-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
2-Etoksi-4-{6-[2-(3-metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Fluoro-4-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-6-propil-benzojeva kiselina;
4-{6-[2-(6-Cijano-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(3-metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
(2-Etoksi-4-{6-[2-(6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
6-{6-[2-(7-Metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzofuran-2-karboksilna kiselina;
2-Difluorometoksi-4-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
6-[6-(2-Benzo[b]tiofen-5-il-etilamino)-pirimidin-4-il]-benzofuran-2-karboksilna kiselina;
5-{6-[2-(7-Kloro-8-metil-kinolin-6-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-[6-(2-Benzotiazol-5-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(7-Metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzofuran-2-karboksilna kiselina;
5-[6-(2-Benzo[b]tiofen-5-il-etilamino)-2-metil-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
4-{6-[2-(7-Cijano-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
(2-Etoksi-4-{6-[2-(7-etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
2-Ciklobutoksi-4-{6-[2-(6-metoksi-benzofuran-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etoksi-4-{6-[2-(1-fluoro-3-metoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
(2-Etoksi-4-{6-[2-(6-metoksi-4-metil-benzofuran-5-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
(2-Etoksi-4-{6-[2-(3-etinil-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
3-Etoksi-5-{6-[2-(7-fluoro-4-metil-3,4-dihidro-2H-benzo[1,4]oksazin-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
2-Etoksi-4-{6-[2-(3-etinil-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etoksi-4-{6-[2-(6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etilsulfanil-4-{6-[2-(7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
5-[6-(2-Benzo[1,3]dioksol-5-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
(2-Etoksi-4-{6-[2-(6-metoksi-benzofuran-5-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
4-{6-[2-(7-Metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
5-{6-[2-(7-Kloro-8-fluoro-kinolin-6-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
(2-Etoksi-4-{6-[2-(6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
5-{6-[2-(6-Difluorometoksi-benzo[1,3]dioksol-5-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
(2-Etoksi-4-{6-[2-(7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
2-Ciklobutoksi-4-{6-[2-(5-metoksi-benzofuran-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-[6-(2-Benzo[b]tiofen-5-il-etilamino)-pirimidin-4-il]-2-ciklobutoksi-benzojeva kiselina;
2-Etoksi-4-{6-[2-(6-etoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-{6-[2-(1-Metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-1H-indol-4-karboksilna kiselina;
4-{6-[2-(6-Cijano-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina;
4-[6-(2-Benzo[b]tiofen-5-il-etilamino)-pirimidin-4-il]-2-metilsulfanil-benzojeva kiselina;
5-[6-(2-Benzo[d]izotiazol-5-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
4-{6-[2-(7-Etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
4-{6-[2-(2,3-Dihidro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
(2-Etoksi-4-{6-[2-(6-metoksi-benzofuran-5-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Etoksi-4-{6-[2-(6-fluoro-benzofuran-5-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
5-[6-(2-Benzooksazol-6-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
(3-Etoksi-5-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-octena kiselina;
2-Etoksi-4-{6-[2-(6-metoksi-benzofuran-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(5-Metoksi-benzo[b]tiofen-6-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
4-[6-(2-Benzo[b]tiofen-5-il-etilamino)-pirimidin-4-il]-2-etoksi-benzojeva kiselina;
(2-Etoksi-4-{6-[2-(6-metoksi-4-metil-benzofuran-5-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
2-Etilsulfanil-4-{6-[2-(6-metoksi-benzofuran-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
(2-Etoksi-4-{6-[2-(5-metoksi-benzofuran-6-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
(2-Etoksi-4-{6-[2-(3-etoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
5-{6-[2-(1,3-Dihidro-izobenzofuran-5-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
2-Butoksi-4-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(2,3-dihidro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(3-etoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etoksi-4-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
5-{6-[2-(4-Kloro-7-metil-kinolin-6-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
4-{6-[2-(1-Metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-propoksi-benzojeva kiselina;
(2-Etoksi-4-{6-[2-(7-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
3-(3-Etoksi-5-{6-[2-(1H-indol-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-[1,2,4]oksadiazol-5(4H)-on;
3-(5-(6-((2-(1H-indol-5-il)etil)amino)pirimidin-4-il)-3-etoksitiofen-2-il)-[1,2,4]oksadiazol-5-ol;
3-{5-[6-(2-Benzo[b]tiofen-5-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-il}-[1,2,4]oksadiazol-5(4H)-on;
3-(5-(6-((2-(Benzo[b]tiofen-5-il)etil)amino)pirimidin-4-il)-3-etoksitiofen-2-il)-[1,2,4]oksadiazol-5-ol;
3-(3-Etoksi-5-{6-[2-(7-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-[1,2,4]oksadiazol-5(4H)-on;
3-(3-Etoksi-5-(6-((2-(7-metil-2,3-dihidrobenzo[b][1,4]dioksin-6-il)etil)amino)pirimidin-4-il)tiofen-2-il)-[1,2,4]oksadiazol-5-ol;
3-(3-Etoksi-5-{6-[2-(6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-[1,2,4]oksadiazol-5(4H)-on;
3-(3-Etoksi-5-(6-((2-(6-metoksibenzo[b]tiofen-5-il)etil)amino)pirimidin-4-il)tiofen-2-il)-[1,2,4]oksadiazol-5-ol;
3-(3-Etoksi-5-{6-[2-(1H-indol-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-[1,2,4]oksadiazol-5(4H)-on;
3-(5-(6-((2-(1H-indol-6-il)etil)amino)pirimidin-4-il)-3-etoksitiofen-2-il)-[1,2,4]oksadiazol-5-ol;
3-{5-[6-(2-Benzo[1,3]dioksol-5-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-il}-[1,2,4]oksadiazol-5(4H)-on;
3-(5-(6-((2-(Benzo[d][1,3]dioksol-5-il)etil)amino)pirimidin-4-il)-3-etoksitiofen-2-il)-[1,2,4]oksadiazol-5-ol;
3-(3-Etoksi-5-{6-[2-(7-fluoro-kinolin-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-[1,2,4]oksadiazol-5(4H)-on;
3-(3-Etoksi-5-(6-((2-(7-fluorokinolin-6-il)etil)amino)pirimidin-4-il)tiofen-2-il)-[1,2,4]oksadiazol-5-ol;
{6-[4-Etoksi-5-(1H-tetrazol-5-il)-tiofen-2-il]-pirimidin-4-il}-[2-(7-fluoro-kinolin-6-il)-etil]-amin;
4-Etoksi-2-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiazol-5-karboksilna kiselina;
3-(4-Etoksi-2-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiazol-5-il)-[1,2,4]oksadiazol-5(4H)-on;
3-(4-Etoksi-2-(6-((2-(1-metilnaftalen-2-il)etil)amino)pirimidin-4-il)tiazol-5-il)-[1,2,4]oksadiazol-5-ol;
3-(4-Etil-2-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiazol-5-il)-[1,2,4]oksadiazol-5(4H)-on;
3-(4-Etil-2-(6-((2-(1-metilnaftalen-2-il)etil)amino)pirimidin-4-il)tiazol-5-il)-[1,2,4]oksadiazol-5-ol;
3-Etoksi-5-(6-((2-(1-metilnaftalen-2-il)etil)amino)pirimidin-4-il)-N-sulfamoiltiofen-2-karboksamid;
N-(3-Etoksi-5-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karbonil)-metansulfonamid;
2-Ciklobutoksi-4-{6-[2-(7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(6-Metil-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
(2-Etoksi-4-{6-[2-(7-etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
4-{6-[2-(6-Metoksi-benzofuran-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(7-etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
6-{6-[2-(7-Metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzofuran-3-karboksilna kiselina;
4-{6-[2-(4-Metil-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(6-metoksi-4-metil-benzofuran-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(3-Cijano-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(6-metoksi-benzo[1,3]dioksol-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etoksi-4-{6-[2-(6-metoksi-4-metil-benzofuran-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
(4-{6-[2-(6-Metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-fenil)-octena kiselina;
2-Etoksi-4-{6-[2-(6-fluoro-benzofuran-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-(2-Etoksi-4-{6-[2-(6-metoksi-benzofuran-5-il)-etilamino]-pirimidin-4-il}-fenoksi)-propionska kiselina;
4-{6-[2-(6-Fluoro-benzofuran-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
4-[6-(2-Benzofuran-5-il-etilamino)-pirimidin-4-il]-2-metilsulfanil-benzojeva kiselina;
4-[6-(2-Benzofuran-6-il-etilamino)-pirimidin-4-il]-2-metilsulfanil-benzojeva kiselina;
2-Etoksi-4-{6-[2-(6-metil-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etoksi-4-{6-[2-(7-etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(4-metil-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(6-Metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(6-Metoksi-benzo[1,3]dioksol-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
2-Etoksi-4-{6-[2-(7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(7-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etoksi-4-{6-[2-(4-metil-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etoksi-4-{6-[2-(6-metoksi-benzo[1,3]dioksol-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
3-Etoksi-5-{6-[2-(1-fluoro-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(6-fluoro-1-metil-1H-indol-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(4-Kloro-3-metoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(8-metoksi-3,4-dihidro-2H-benzo[b][1,4]dioksepin-7-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(8-metil-kinolin-7-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(3-izopropoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(1-Cijano-naftalen-2-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-[6-(2-naftalen-2-il-etilamino)-pirimidin-4-il]-tiofen-2-karboksilna kiselina;
(2-Etoksi-4-{6-[2-(1-fluoro-3-metoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
3-Etoksi-5-{6-[2-(3-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-[6-(2-indan-5-il-etilamino)-pirimidin-4-il]-tiofen-2-karboksilna kiselina;
5-{6-[2-(8-Kloro-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
4-{6-[2-(3-Cijano-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina;
5-{6-[2-(4,5-Difluoro-7-metoksi-2-metil-benzofuran-6-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-[6-(2-Kroman-7-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(3-metoksi-5,6,7,8-tetrahidro-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
(2-Etoksi-4-{6-[2-(3-metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
5-{6-[2-(3-Kloro-naftalen-2-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(1-metil-1H-indol-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(8-fluoro-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(5-fluoro-kinolin-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
2-Ciklobutoksi-4-{6-[2-(7-metilsulfanil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
5-{6-[2-(1-Amino-naftalen-2-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(7-Fluoro-1-metil-1,2,3,4-tetrahidro-kinolin-6-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
4-{6-[2-(3-Cijano-1-fluoro-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina;
3-Etoksi-5-{6-[2-(1-vinil-naftalen-2-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
2-Izobutil-4-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
3-Etoksi-5-{6-[2-(7-metilsulfanil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
(4-{6-[2-(6-Cijano-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenil)-octena kiselina;
(4-{6-[2-(3-Cijano-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenoksi)-octena kiselina;
5-{6-[2-(5,8-Difluoro-kinolin-6-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
(2-Etoksi-4-{6-[2-(3-izopropoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
5-{6-[2-(1-Kloro-naftalen-2-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-[6-(2-Benzotiazol-6-il-etilamino)-pirimidin-4-il]-3-etoksi-tiofen-2-karboksilna kiselina;
4-{6-[2-(3-Cijano-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina;
3-Etoksi-5-{6-[2-(4-fluoro-7-metoksi-2-metil-benzo[b]tiofen-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(8-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(7-fluoro-kinolin-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(6-fluoro-izokinolin-7-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
(4-{6-[2-(1,3-Difluoro-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenil)-octena kiselina;
5-{6-[2-(7-Fluoro-izokinolin-6-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
4-{6-[2-(7-Cijano-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-ciklobutoksi-benzojeva kiselina;
5-{6-[2-(2,3-Dihidro-benzofuran-5-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
(4-{6-[2-(1-Fluoro-3-metoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-fenil)-octena kiselina;
{4-[6-(2-Benzo[b]tiofen-5-il-etilamino)-pirimidin-4-il]-2-etoksi-fenoksi}-octena kiselina;
(2-Etoksi-4-{6-[2-(3-metoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
2-Etoksi-4-{6-[2-(4-fluoro-3-metoksi-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
5-{6-[2-(1,3-Difluoro-naftalen-2-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-{3-Etoksi-5-[6-(2-kinolin-6-il-etilamino)-pirimidin-4-il]-tiofen-2-il}-[1,2,4]oksadiazol-5(4H)-on;
3-(3-Etoksi-5-(6-((2-(kinolin-6-il)etil)amino)pirimidin-4-il)tiofen-2-il)-[1,2,4]oksadiazol-5-ol;
3-{3-Etoksi-5-[6-(2-naftalen-2-il-etilamino)-pirimidin-4-il]-tiofen-2-il}-[1,2,4]oksadiazol-5(4H)-on; i
3-(3-Etoksi-5-(6-((2-(naftalen-2-il)etil)amino)pirimidin-4-il)tiofen-2-il)-[1,2,4]oksadiazol-5-ol;
ili njihove farmaceutski prihvatljive soli.
9. Spoj prema patentnom zahtjevu 2, naznačen time, da se bira iz skupine koju čine:
5-{6-[2-(7-Kloro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
4-{6-[2-(7-Kloro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
2-Etoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
3-Etoksi-5-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
2-Etoksi-4-{6-[2-(4-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(4-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
3-Etoksi-5-{6-[2-(4-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
4-{6-[2-(4-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
(2-Etoksi-6-fluoro-4-{6-[2-(6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Etoksi-6-fluoro-4-{6-[2-(4-metil-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
3-Etoksi-5-{6-[2-(7-metil-benzo[b]tiofen-6-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
4-{6-[2-(6-Metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propil-benzojeva kiselina;
4-{6-[2-(4-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propil-benzojeva kiselina;
4-{6-[2-(7-Metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-propil-benzojeva kiselina;
4-{6-[2-(3-Metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-propil-benzojeva kiselina;
(2-Metoksi-4-{6-[2-(6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(4-{6-[2-(4-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metoksi-fenil)-octena kiselina;
(2-Metoksi-4-{6-[2-(7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Metoksi-4-{6-[2-(3-metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(4-{6-[2-(6-Metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
(4-{6-[2-(4-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
(4-{6-[2-(7-Metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
(4-{6-[2-(3-Metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propil-benzojeva kiselina;
3-Etoksi-5-{6-[2-(7-metil-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
(4-{6-[2-(4-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propoksi-fenil)-octena kiselina;
(4-{6-[2-(3-Metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-propoksi-fenil)-octena kiselina;
2-Etoksi-4-{6-[2-(7-metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(7-metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
(4-{6-[2-(7-Metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
(2-Etoksi-6-fluoro-4-{6-[2-(7-metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Etoksi-4-{6-[2-(7-metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
4-{6-[2-(7-Metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
(4-{6-[2-(7-Etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
(2-Etoksi-4-{6-[2-(7-etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-6-fluoro-fenil)-octena kiselina;
2-Etoksi-4-{6-[2-(7-fluoro-6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(7-Fluoro-6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
(2-Etoksi-4-{6-[2-(7-fluoro-6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
2-Ciklobutoksi-4-{6-[2-(7-fluoro-6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
(4-{6-[2-(5-Fluoro-7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
(4-{6-[2-(7-Fluoro-6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-izobutil-fenil)-octena kiselina;
(2-Izobutil-4-{6-[2-(7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(4-{6-[2-(7-Etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-izobutil-fenil)-octena kiselina;
4-{6-[2-(4-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-izobutil-benzojeva kiselina;
4-{6-[2-(7-Fluoro-6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-izobutil-benzojeva kiselina;
4-{6-[2-(7-Etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-izobutil-benzojeva kiselina;
2-Etoksi-4-{6-[2-(3-etoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(3-Etoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
(2-Etoksi-4-{6-[2-(3-etoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
3-(2-Etoksi-4-{6-[2-(4-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenoksi)-propionska kiselina;
3-(2-Etoksi-4-{6-[2-(3-metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenoksi)-propionska kiselina;
(4-{6-[2-(7-Etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-izopropoksi-fenil)-octena kiselina;
(2-Izopropoksi-4-{6-[2-(7-metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(4-{6-[2-(7-Etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-trifluorometoksi-fenil)-octena kiselina;
(4-{6-[2-(7-Metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-trifluorometoksi-fenil)-octena kiselina;
4-{6-[2-(3-Kloro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
4-{6-[2-(3-Kloro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-ciklobutoksi-benzojeva kiselina;
(4-{6-[2-(3-Kloro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenil)-octena kiselina;
2-Izopropoksi-4-{6-[2-(7-metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
5-{6-[2-(7-Difluorometoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
(2-Metoksi-4-{6-[2-(7-metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
2-Etoksi-4-{6-[2-(5-fluoro-7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etoksi-4-{6-[2-(3-etoksi-1-fluoro-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
3-(4-{6-[2-(4-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metoksi-fenoksi)-propionska kiselina;
2-Etoksi-4-{6-[2-(7-etinil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
(4-{6-[2-(7-Etinil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
(2-Difluorometoksi-4-{6-[2-(7-metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Difluorometoksi-4-{6-[2-(5-fluoro-7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Difluorometoksi-4-{6-[2-(3-metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Etil-4-{6-[2-(7-metoksi-5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Etil-4-{6-[2-(3-metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
2-Etil-4-{6-[2-(3-metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklopropoksi-4-{6-[2-(7-etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklopropoksi-4-{6-[2-(3-metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklopropoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
(4-{6-[2-(7-Metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-trifluorometoksi-fenil)-octena kiselina;
3-(2-Etoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-[1,2,4]oksadiazol-5(4H)-on;
3-(2-Etoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-[1,2,4]oksadiazol-5-ol;
{6-[3-Etoksi-4-(1H-tetrazol-5-il)-fenil]-pirimidin-4-il}-[2-(7-fluoro-benzo[b]tiofen-5-il)-etil]-amin;
4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-izobutoksi-benzojeva kiselina;
(3-Etoksi-5-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-octena kiselina;
4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propil-benzamid;
4-{6-[2-(7-Fluoro-6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propil-benzojeva kiselina;
3-Etoksi-5-{6-[2-(7-fluoro-6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
(4-{6-[2-(7-Fluoro-6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metoksi-fenil)-octena kiselina;
(4-{6-[2-(7-Fluoro-6-metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
2-(4-{6-[2-(7-Etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-propionska kiselina;
4-{6-[2-(3-Kloro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina;
4-{6-[2-(7-Difluorometoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-metilsulfanil-benzojeva kiselina;
(4-{6-[2-(3-Kloro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
(4-{6-[2-(3-Kloro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-trifluorometoksi-fenil)-octena kiselina;
(4-{6-[2-(3-Metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-trifluorometoksi-fenil)-octena kiselina;
(4-{6-[2-(7-Etinil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-metoksi-fenil)-octena kiselina;
(4-{6-[2-(5-Metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
(2-Difluorometoksi-4-{6-[2-(7-etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
2-Etil-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklopropoksi-4-{6-[2-(7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklopropoksi-4-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
(3-Difluorometoksi-5-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-octena kiselina;
3-(2-Etoksi-4-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenil)-[1,2,4]oksadiazol-5(4H)-tion;
3-(2-Etoksi-4-{6-[2-(1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenil)-[1,2,4]oksadiazol-5-tiol;
(4-{6-[2-(6-Metoksi-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propoksi-fenil)-octena kiselina;
2-Butoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etoksi-4-{6-[2-(5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
(4-{6-[2-(5-Metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-trifluorometoksi-fenil)-octena kiselina;
(4-{6-[2-(7-Etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-etil-fenil)-octena kiselina;
2-Etil-4-{6-[2-(5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(7-Etoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-etil-benzojeva kiselina;
2-Ciklopropoksi-4-{6-[2-(5-metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
(4-{6-[2-(7-Metil-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
(4-{6-[2-(3-Cijano-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenil)-octena kiselina;
(2-Etoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Etoksi-4-{6-[2-(4-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Etoksi-6-fluoro-4-{6-[2-(3-metoksi-1-metil-naftalen-2-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Etoksi-6-fluoro-4-{6-[2-(4-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-octena kiselina;
(4-{6-[2-(4-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-izobutil-fenil)-octena kiselina;
4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-izobutil-benzojeva kiselina;
2-Izobutil-4-{6-[2-(7-metoksi-2,3-dihidro-benzo[1,4]dioksin-6-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
3-(2-Etoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenoksi)-propionska kiselina;
(4-{6-[2-(4-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-izopropoksi-fenil)-octena kiselina;
3-(4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metoksi-fenoksi)-propionska kiselina;
3-Etil-5-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
2-Etoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-N-(2-hidroksi-etil)-benzamide;
(4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metoksi-fenil)-octena kiselina;
2-{4-[6-(2-Benzo[b]tiofen-5-il-etilamino)-pirimidin-4-il]-2-propil-fenil}-propionska kiselina;
2-(4-{6-[2-(4-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-propil-fenil)-propionska kiselina;
3-Etoksi-5-{6-[2-(7-trifluorometil-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-(4-(6-((2-(7-fluorobenzo[b]tiofen-5-il)etil)amino)pirimidin-4-il)fenil)-[1,2,4]oksadiazol-5(4H)-on;
3-(4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-[1,2,4]oksadiazol-5-ol;
7-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-1-metil-3,4-dihidro-1H-kinazolin-2-on;
4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2,6-dimetil-fenol;
2-Etilsulfanil-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Ciklobutoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
3-(3-Etoksi-5-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-propionska kiselina;
3-(4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-4-hidroksi-ciklobut-3-en-1,2-dion;
(2-Etoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-okso-octena kiselina;
2-Ciklopropoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina metil ester;
(2-Kloro-6-etil-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-octena kiselina;
(2-Etil-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-6-metil-fenil)-octena kiselina;
(3-Etil-5-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-octena kiselina;
5-(2-Etoksi-4-{6-[2-(7-fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-fenil)-izoksazol-3-ol;
5-(2-etoksi-4-(6-((2-(7-fluorobenzo[b]tiofen-5-il)etil)amino)pirimidin-4-il)fenil)izoksazol-3(2H)-on;
5-(4-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-2-metoksi-fenil)-izoksazol-3-ol;
5-(4-(6-((2-(7-fluorobenzo[b]tiofen-5-il)etil)amino)pirimidin-4-il)-2-metoksifenil)izoksazol-3(2H)-on; i
(5-{6-[2-(7-Fluoro-benzo[b]tiofen-5-il)-etilamino]-pirimidin-4-il}-3-propil-tiofen-2-il)-octena kiselina;
ili njihove farmaceutski prihvatljive soli.
10. Farmaceutski pripravak, naznačen time, da sadrži, kao aktivni sastavni dio, spoj u skladu s bilo kojim od patentnih zahtjeva 2 do 9, ili njegovu farmaceutski prihvatljivu sol, te najmanje jedno terapijski inertno pomoćno sredstvo.
11. Spoj prema bilo kojem od patentnih zahtjeva 2 do 9, ili njegova farmaceutski prihvatljiva sol, naznačeni time, da su za uporabu kao lijek.
12. Spoj prema bilo kojem od patentnih zahtjeva 2 do 9, ili njegova farmaceutski prihvatljiva sol, naznačeni time, da su za uporabu u prevenciji ili liječenju bolesti odabrane iz skupine koja se sastoji od raka; boli; endometrioze; autosomalne dominantne policistične bolesti bubrega; akutnog ishemijskog sindroma kod ateroskleroznog pacijenta; pneumonije; i neurodegenerativnih bolesti; ili za uporabu u kontroliranju ženske plodnosti.
13. Spoj prema bilo kojem od patentnih zahtjeva 2 do 9, ili njegova farmaceutski prihvatljiva sol, naznačeni time, da su za uporabu u prevenciji ili liječenju raka odabranog od melanoma; raka pluća; raka mokraćnog mjehura; renalnog karcinoma; raka gastrointestinalnog trakta; raka endometrija; raka jajnika; raka grlića maternice; i neuroblastoma.
14. Uporaba spoja prema bilo kojem od patentnih zahtjeva 2 do 9, ili njegove farmaceutski prihvatljive soli, naznačena time, da je za proizvodnju lijeka za prevenciju ili liječenje bolesti odabrane iz skupine koja se sastoji od raka; boli; endometrioze; autosomalne dominantne policistične bolesti bubrega; akutnog ishemijskog sindroma kod ateroskleroznog pacijenta; pneumonije; i neurodegenerativnih bolesti; ili za kontroliranje ženske plodnosti.
15. Spoj prema bilo kojem od patentnih zahtjeva 2 do 9, ili njegova farmaceutski prihvatljiva sol, naznačeni time, da su za uporabu u liječenju raka, gdje se navedeni rak liječi pomoću modulacije imunosnog odgovora koji sadrži reaktivaciju imunosnog sustava u tumoru; pri čemu se navedeni spoj opcionalno upotrebljava u kombinaciji s jednim ili više kemoterapijskih sredstava i / ili s radioterapijom i / ili sa ciljanom terapijom.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2017061989 | 2017-05-18 | ||
PCT/EP2018/062844 WO2018210988A1 (en) | 2017-05-18 | 2018-05-17 | Pyrimidine derivatives as pge2 receptor modulators |
EP18725498.2A EP3625228B1 (en) | 2017-05-18 | 2018-05-17 | Pyrimidine derivatives as pge2 receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20211380T1 true HRP20211380T1 (hr) | 2021-11-26 |
Family
ID=62196584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20211380TT HRP20211380T1 (hr) | 2017-05-18 | 2021-08-30 | Derivati pirimidina kao modulatori receptora pge2 |
Country Status (32)
Country | Link |
---|---|
US (1) | US11839613B2 (hr) |
EP (1) | EP3625228B1 (hr) |
JP (1) | JP7159215B2 (hr) |
KR (1) | KR102626982B1 (hr) |
CN (1) | CN110612299A (hr) |
AR (1) | AR111808A1 (hr) |
AU (1) | AU2018268311B2 (hr) |
BR (1) | BR112019024105A2 (hr) |
CA (1) | CA3060394A1 (hr) |
CL (1) | CL2019003274A1 (hr) |
CO (1) | CO2019010505A2 (hr) |
CR (1) | CR20190560A (hr) |
CY (1) | CY1124799T1 (hr) |
DK (1) | DK3625228T3 (hr) |
EA (1) | EA201992677A1 (hr) |
ES (1) | ES2887041T3 (hr) |
HR (1) | HRP20211380T1 (hr) |
HU (1) | HUE056382T2 (hr) |
IL (1) | IL270620B2 (hr) |
LT (1) | LT3625228T (hr) |
MA (1) | MA49128A (hr) |
MX (1) | MX2019013638A (hr) |
PE (1) | PE20191811A1 (hr) |
PH (1) | PH12019502564A1 (hr) |
PL (1) | PL3625228T3 (hr) |
PT (1) | PT3625228T (hr) |
RS (1) | RS62398B1 (hr) |
SG (1) | SG11201908097YA (hr) |
SI (1) | SI3625228T1 (hr) |
TW (1) | TW201900178A (hr) |
UA (1) | UA125124C2 (hr) |
WO (1) | WO2018210988A1 (hr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CR20180323A (es) | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
ES2929309T3 (es) | 2017-05-18 | 2022-11-28 | Idorsia Pharmaceuticals Ltd | Derivados de benzofurano y benzotiofeno como moduladores del receptor PGE2 |
AR111874A1 (es) | 2017-05-18 | 2019-08-28 | Idorsia Pharmaceuticals Ltd | Derivados de pirimidina |
PL3625222T3 (pl) | 2017-05-18 | 2021-12-27 | Idorsia Pharmaceuticals Ltd | Pochodne fenylu jako modulatory receptora pge2 |
WO2021060281A1 (ja) * | 2019-09-24 | 2021-04-01 | Agc株式会社 | プロスタグランジンe2レセプターep2/ep4デュアルアンタゴニスト |
EP4245301A1 (en) | 2020-11-13 | 2023-09-20 | ONO Pharmaceutical Co., Ltd. | Cancer treatment by combined use of ep4 antagonist and immune checkpoint inhibitor |
CN113248354B (zh) * | 2021-07-07 | 2022-04-22 | 山东国邦药业有限公司 | 一种氟氯苯乙酮的合成方法 |
CN114539193A (zh) * | 2022-01-20 | 2022-05-27 | 海南普利制药股份有限公司 | 一种盐酸胺碘酮中间体的制备方法 |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948786A (en) | 1996-04-12 | 1999-09-07 | Sumitomo Pharmaceuticals Company, Limited | Piperidinylpyrimidine derivatives |
CA2402099C (en) | 2000-03-24 | 2011-04-26 | Pharmagene Laboratories Ltd. | Methods for the treatment of primary headache disorders using prostanoid ep4 receptor antagonists, and assays for agents for such treatment |
HN2001000224A (es) | 2000-10-19 | 2002-06-13 | Pfizer | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos. |
GB0031295D0 (en) | 2000-12-21 | 2001-01-31 | Glaxo Group Ltd | Naphthalene derivatives |
GB0031302D0 (en) | 2000-12-21 | 2001-01-31 | Glaxo Group Ltd | Napthalene derivatives |
GB0103269D0 (en) | 2001-02-09 | 2001-03-28 | Glaxo Group Ltd | Napthalene derivatives |
WO2003087061A1 (en) | 2002-04-12 | 2003-10-23 | Pfizer Japan Inc. | Pyrazole compounds as anti-inflammatory and analgesic agents |
BR0309305A (pt) | 2002-04-12 | 2005-02-15 | Pfizer | Compostos de imidazol como agentes antiinflamatórios e analgésicos |
CN1662551A (zh) | 2002-05-23 | 2005-08-31 | 瑟瑞技术公司 | 前列腺素e2受体亚型ep4的拮抗肽 |
ES2308139T3 (es) | 2003-01-29 | 2008-12-01 | Asterand Uk Limited | Antagonista de receptos ep4. |
WO2005019218A1 (ja) | 2003-08-26 | 2005-03-03 | Teijin Pharma Limited | ピロロピリミジンチオン誘導体 |
OA13247A (en) | 2003-09-03 | 2007-01-31 | Pfizer | Phenyl or pyridyl amide coumpounds as prostaglandin E2 antagonists. |
EP1678147B1 (en) | 2003-09-15 | 2012-08-08 | Lead Discovery Center GmbH | Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
KR20070006891A (ko) | 2004-05-04 | 2007-01-11 | 화이자 인코포레이티드 | 치환된 메틸 아릴 또는 헤테로아릴 아미드 화합물 |
WO2005105733A1 (en) | 2004-05-04 | 2005-11-10 | Pfizer Japan Inc. | Ortho substituted aryl or heteroaryl amide compounds |
HN2005000795A (es) | 2004-10-15 | 2010-08-19 | Aventis Pharma Inc | Pirimidinas como antagonistas del receptor de prostaglandina d2 |
JP5289046B2 (ja) | 2005-05-19 | 2013-09-11 | メルク カナダ インコーポレイテッド | Ep4アンタゴニストとしてのキノリン誘導体 |
WO2006128129A2 (en) | 2005-05-26 | 2006-11-30 | Synta Pharmaceuticals Corp. | Method for treating cancer |
DOP2007000068A (es) | 2006-04-12 | 2007-10-31 | Sanofi Aventis Us Llc | Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos como antagonistas del receptor de prostaglandina d2 |
WO2007121578A1 (en) | 2006-04-24 | 2007-11-01 | Merck Frosst Canada Ltd. | Indole amide derivatives as ep4 receptor antagonists |
WO2007143825A1 (en) | 2006-06-12 | 2007-12-21 | Merck Frosst Canada Ltd. | Indoline amide derivatives as ep4 receptor ligands |
US20080280891A1 (en) | 2006-06-27 | 2008-11-13 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
WO2008008059A1 (en) | 2006-07-12 | 2008-01-17 | Locus Pharmaceuticals, Inc. | Anti-cancer agents ans uses thereof |
AR061974A1 (es) | 2006-07-14 | 2008-08-10 | Novartis Ag | Derivados de pirimidina como inhibidores de alk, composiciones farmaceuticas y procesos de obtencion |
AU2007283404B2 (en) | 2006-08-11 | 2013-04-18 | Merck Canada Inc. | Thiophenecarboxamide derivatives as EP4 receptor ligands |
WO2008039882A1 (en) | 2006-09-30 | 2008-04-03 | Sanofi-Aventis U.S. Llc | A combination of niacin and a prostaglandin d2 receptor antagonist |
US8158671B2 (en) | 2007-02-26 | 2012-04-17 | Merck Canada Inc. | Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists |
CA2681146A1 (en) | 2007-03-26 | 2008-10-02 | Merck Frosst Canada Ltd. | Naphthalene and quinoline sulfonylurea derivatives as ep4 receptor antagonists |
CN101641325A (zh) | 2007-03-26 | 2010-02-03 | 安斯泰来制药株式会社 | 鸟氨酸衍生物 |
EP2014657A1 (de) | 2007-06-21 | 2009-01-14 | Bayer Schering Pharma Aktiengesellschaft | Diaminopyrimidine als Modulatoren des EP2-Rezeptors |
WO2009005076A1 (ja) | 2007-07-03 | 2009-01-08 | Astellas Pharma Inc. | アミド化合物 |
EP2212297B1 (en) | 2007-10-12 | 2011-05-25 | Ingenium Pharmaceuticals GmbH | Inhibitors of protein kinases |
CA2714743C (en) | 2008-02-19 | 2017-01-17 | Janssen Pharmaceutica N.V. | Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase |
US8598355B2 (en) | 2008-05-14 | 2013-12-03 | Astellas Pharma Inc. | Amide compound |
US20130225528A1 (en) | 2008-05-21 | 2013-08-29 | Ariad Pharmaceuticals, Inc. | Phosphorus Derivatives as Kinase Inhibitors |
WO2010019796A1 (en) | 2008-08-14 | 2010-02-18 | Chemietek, Llc | Heterocyclic amide derivatives as ep4 receptor antagonists |
GB2474813B (en) | 2008-09-19 | 2014-05-28 | Biotechnology Res Corp Ltd | Triterpenoid compounds and methods of use thereof |
WO2010034110A1 (en) | 2008-09-25 | 2010-04-01 | Merck Frosst Canada Ltd. | Beta-carboline sulphonylurea derivatives as ep4 receptor antagonists |
US8906914B2 (en) * | 2009-08-18 | 2014-12-09 | Janssen Pharmaceutica Nv | Ethylene diamine modulators of fatty acid hydrolase |
US20110124667A1 (en) | 2009-11-23 | 2011-05-26 | Philip Manton Brown | Methods for the treatment of irritable bowel syndrome |
CA2798578C (en) | 2010-05-21 | 2015-12-29 | Chemilia Ab | Novel pyrimidine derivatives |
RU2606510C2 (ru) | 2010-09-21 | 2017-01-10 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Фармацевтическая композиция |
WO2012043634A1 (ja) | 2010-09-29 | 2012-04-05 | 株式会社エヌビィー健康研究所 | ヒトプロスタグランジンe2受容体ep4に対する抗体 |
WO2012066065A1 (en) | 2010-11-17 | 2012-05-24 | Novartis Ag | Phenyl-heteroaryl amine compounds and their uses |
US20130324530A1 (en) | 2010-11-17 | 2013-12-05 | Novartis Ag | 3-(aminoaryl)-pyridine compounds |
ES2545110T3 (es) | 2010-12-10 | 2015-09-08 | Rottapharm Biotech S.R.L. | Derivados de piridinamida como antagonistas del receptor EP4 |
WO2012103071A2 (en) | 2011-01-25 | 2012-08-02 | Eisai R&D Management Co., Ltd. | Compounds and compositions |
CA2830129C (en) | 2011-03-24 | 2016-07-19 | Chemilia Ab | Novel pyrimidine derivatives |
WO2012149528A1 (en) | 2011-04-29 | 2012-11-01 | Exelixis, Inc. | Inhibitors of inducible form of 6-phosphofructose-2-kinase |
US9518044B2 (en) | 2011-06-20 | 2016-12-13 | Emory University | Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto |
JP5813223B2 (ja) | 2011-07-04 | 2015-11-17 | ロッタファーム バイオテック エス アール エル | Ep4レセプターアンタゴニストとしての環状アミン誘導体 |
EP2554662A1 (en) | 2011-08-05 | 2013-02-06 | M Maria Pia Cosma | Methods of treatment of retinal degeneration diseases |
WO2013090552A1 (en) | 2011-12-13 | 2013-06-20 | Yale University | Compositions and methods for reducing ctl exhaustion |
SG11201406584TA (en) * | 2012-04-24 | 2014-11-27 | Vertex Pharma | Dna-pk inhibitors |
TWI572597B (zh) | 2012-06-29 | 2017-03-01 | 美國禮來大藥廠 | 二甲基-苯甲酸化合物 |
AR091429A1 (es) | 2012-06-29 | 2015-02-04 | Lilly Co Eli | Compuestos de fenoxietil piperidina |
EP2711364A1 (en) | 2012-09-21 | 2014-03-26 | Chemilia AB | 4-(Indolyl or benzimidazolyl)amino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer |
CA2888338C (en) | 2012-11-27 | 2021-07-20 | Thomas Helledays Stiftelse For Medicinsk Forskning | Mth1 inhibitors for treatment of cancer |
UA115576C2 (uk) | 2012-12-06 | 2017-11-27 | Байєр Фарма Акцієнгезелльшафт | Похідні бензимідазолу як антагоністи ер4 |
EP2765128A1 (en) | 2013-02-07 | 2014-08-13 | Almirall, S.A. | Substituted benzamides with activity towards EP4 receptors |
TW201443004A (zh) | 2013-02-15 | 2014-11-16 | Lilly Co Eli | 苯氧基乙氧基化合物 |
TWI636046B (zh) | 2013-05-17 | 2018-09-21 | 美國禮來大藥廠 | 苯氧基乙基二氫-1h-異喹啉化合物 |
CA2912133C (en) | 2013-05-30 | 2021-06-22 | Actelion Pharmaceuticals Ltd | Cxcr7 receptor modulators |
ES2669977T3 (es) | 2013-06-12 | 2018-05-29 | Kaken Pharmaceutical Co., Ltd. | Derivado de 4-alquinilimidazol y medicamento que lo comprende como ingrediente activo |
AU2014315457B2 (en) | 2013-09-04 | 2018-05-10 | Bristol-Myers Squibb Company | Compounds useful as immunomodulators |
PT3363790T (pt) | 2013-09-06 | 2020-05-06 | Aurigene Discovery Tech Ltd | Derivados 1,2,4-oxadiazoles como imunomoduladores |
WO2015044900A1 (en) | 2013-09-27 | 2015-04-02 | Aurigene Discovery Technologies Limited | Therapeutic immunomodulating compounds |
CN105636958B (zh) * | 2013-10-17 | 2018-01-05 | 沃泰克斯药物股份有限公司 | Dna‑pk抑制剂 |
DK3057953T3 (en) | 2013-10-17 | 2018-11-19 | Vertex Pharma | CO CRYSTALS OF (S) -N-METHYL-8- (1 - ((2'-METHYL- [4,5'-BIPYRIMIDIN] -6-YL) AMINO) PROPAN-2-YL) QUINOLIN-4-CARBOXAMIDE AND DEUTERATED DERIVATIVES THEREOF AS DNA-PK INHIBITORS |
EA028675B1 (ru) | 2013-12-17 | 2017-12-29 | Эли Лилли Энд Компани | Соединения диметилбензойной кислоты |
EP3083562B1 (en) | 2013-12-17 | 2017-09-27 | Eli Lilly & Company | Phenoxyethyl cyclic amine derivatives and their activity as ep4 receptor modulators |
TW201607943A (zh) | 2013-12-19 | 2016-03-01 | 拜耳製藥公司 | 作為ep4配體之新穎苯并咪唑衍生物 |
TW201623277A (zh) | 2014-03-26 | 2016-07-01 | 安斯泰來製藥股份有限公司 | 醯胺化合物 |
EP3137074B1 (en) | 2014-04-29 | 2020-08-05 | Emory University | Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto |
AU2015264102C1 (en) | 2014-05-23 | 2020-10-08 | Eisai R&D Management Co., Ltd. | Combination therapies for the treatment of cancer |
EP3151833A4 (en) | 2014-06-04 | 2018-01-10 | Thomas Helledays Stiftelse För Medicinsk Forskning | Mth1 inhibitors for treatment of inflammatory and autoimmune conditions |
CN110526912B (zh) | 2014-06-19 | 2023-02-14 | 武田药品工业株式会社 | 用于激酶抑制的杂芳基化合物 |
WO2016021742A1 (en) | 2014-08-07 | 2016-02-11 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds as ep4 receptor antagonists |
TWI739666B (zh) | 2015-01-09 | 2021-09-11 | 日商小野藥品工業股份有限公司 | 醫藥組成物 |
DK3325490T3 (da) | 2015-07-23 | 2020-02-03 | Takeda Pharmaceuticals Co | 1-substituerede 1,2,3,4-tetrahydro-1,7-naphthyridin-8-aminderivater og deres anvendelse som ep4-receptorantagonister |
JP6860559B2 (ja) | 2015-10-16 | 2021-04-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Ep4アンタゴニスト |
CR20180323A (es) | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
WO2018013840A1 (en) | 2016-07-13 | 2018-01-18 | Vertex Pharmaceuticals Incorporated | Methods, compositions and kits for increasing genome editing efficiency |
ES2894124T3 (es) | 2017-05-18 | 2022-02-11 | Idorsia Pharmaceuticals Ltd | Derivados de indol N-sustituidos |
PL3625222T3 (pl) | 2017-05-18 | 2021-12-27 | Idorsia Pharmaceuticals Ltd | Pochodne fenylu jako modulatory receptora pge2 |
ES2929309T3 (es) | 2017-05-18 | 2022-11-28 | Idorsia Pharmaceuticals Ltd | Derivados de benzofurano y benzotiofeno como moduladores del receptor PGE2 |
AR111874A1 (es) | 2017-05-18 | 2019-08-28 | Idorsia Pharmaceuticals Ltd | Derivados de pirimidina |
-
2018
- 2018-05-17 CN CN201880030982.5A patent/CN110612299A/zh active Pending
- 2018-05-17 CA CA3060394A patent/CA3060394A1/en active Pending
- 2018-05-17 US US16/614,209 patent/US11839613B2/en active Active
- 2018-05-17 EP EP18725498.2A patent/EP3625228B1/en active Active
- 2018-05-17 AU AU2018268311A patent/AU2018268311B2/en not_active Ceased
- 2018-05-17 MA MA049128A patent/MA49128A/fr unknown
- 2018-05-17 PL PL18725498T patent/PL3625228T3/pl unknown
- 2018-05-17 PT PT187254982T patent/PT3625228T/pt unknown
- 2018-05-17 LT LTEPPCT/EP2018/062844T patent/LT3625228T/lt unknown
- 2018-05-17 UA UAA201911976A patent/UA125124C2/uk unknown
- 2018-05-17 AR ARP180101313A patent/AR111808A1/es unknown
- 2018-05-17 PE PE2019002395A patent/PE20191811A1/es unknown
- 2018-05-17 SI SI201830403T patent/SI3625228T1/sl unknown
- 2018-05-17 BR BR112019024105-1A patent/BR112019024105A2/pt unknown
- 2018-05-17 MX MX2019013638A patent/MX2019013638A/es unknown
- 2018-05-17 KR KR1020197037039A patent/KR102626982B1/ko active IP Right Grant
- 2018-05-17 SG SG11201908097Y patent/SG11201908097YA/en unknown
- 2018-05-17 RS RS20211222A patent/RS62398B1/sr unknown
- 2018-05-17 DK DK18725498.2T patent/DK3625228T3/da active
- 2018-05-17 TW TW107116710A patent/TW201900178A/zh unknown
- 2018-05-17 ES ES18725498T patent/ES2887041T3/es active Active
- 2018-05-17 JP JP2019563493A patent/JP7159215B2/ja active Active
- 2018-05-17 EA EA201992677A patent/EA201992677A1/ru unknown
- 2018-05-17 WO PCT/EP2018/062844 patent/WO2018210988A1/en unknown
- 2018-05-17 HU HUE18725498A patent/HUE056382T2/hu unknown
- 2018-05-17 CR CR20190560A patent/CR20190560A/es unknown
-
2019
- 2019-09-26 CO CONC2019/0010505A patent/CO2019010505A2/es unknown
- 2019-11-13 IL IL270620A patent/IL270620B2/en unknown
- 2019-11-14 CL CL2019003274A patent/CL2019003274A1/es unknown
- 2019-11-15 PH PH12019502564A patent/PH12019502564A1/en unknown
-
2021
- 2021-08-30 HR HRP20211380TT patent/HRP20211380T1/hr unknown
- 2021-10-06 CY CY20211100870T patent/CY1124799T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20211380T1 (hr) | Derivati pirimidina kao modulatori receptora pge2 | |
JP2020520358A5 (hr) | ||
AR114667A2 (es) | Octahidropirrolo[3,4-c]pirroles disustituidos como moduladores del receptor de orexina | |
IL259424A (en) | History of indole converted to nitrogen as pge2 receptor modulators | |
US7265152B2 (en) | Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases | |
PH12014501365B1 (en) | Compounds | |
RU2019123031A (ru) | (аза)индол-, бензотиофен- и бензофуран-3-сульфонамиды | |
JP2020520354A5 (hr) | ||
JP2020520357A5 (hr) | ||
JP2008239617A (ja) | 医薬 | |
JP2007516173A5 (hr) | ||
AU2005207946A1 (en) | Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer | |
CA2494962A1 (en) | Tyrosine kinase inhibitors | |
CN101146802A (zh) | 噻二唑取代的香豆素衍生物及其作为白三烯生物合成抑制剂的用途 | |
JP2014520885A5 (hr) | ||
RU2016111138A (ru) | Гетероциклические соединения и способы их применения | |
KR20060093735A (ko) | Mmp 억제제로서의 비아릴 설폰아미드 | |
JP2018507234A5 (hr) | ||
JP2012520238A5 (hr) | ||
RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
RU2013136777A (ru) | Новые производные арил-бензоциклоалкиламида | |
HRP20211533T1 (hr) | Derivati fenila kao modulatori receptora pge2 | |
RU2017118562A (ru) | Соединения-антагонисты дофаминового d3-рецептора | |
RU2019122999A (ru) | Новое соединение и его фармакологически приемлемая соль | |
JP2013519716A5 (hr) |